{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T01:21:00Z","timestamp":1771982460326,"version":"3.50.1"},"reference-count":639,"publisher":"Open Exploration Publishing","license":[{"start":{"date-parts":[[2026,1,4]],"date-time":"2026-01-04T00:00:00Z","timestamp":1767484800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Explor Neuroprot Ther"],"accepted":{"date-parts":[[2025,11,24]]},"abstract":"<jats:p xml:lang=\"en\">Neurodegenerative diseases, including Alzheimer\u2019s, Parkinson\u2019s, Huntington\u2019s, and Amyotrophic Lateral Sclerosis, are characterized by multifactorial pathologies that extend beyond neuronal loss to include neuroinflammation, oxidative stress, mitochondrial dysfunction, and glial dysregulation. Despite extensive research, disease-modifying therapies remain elusive, hindered by late diagnosis, limited availability of specific biomarkers, and the persistent dominance of reductionist, single-target strategies. This comprehensive and informative review provides a critical synthesis of integrated neuroprotective strategies, with particular focus on glial mechanisms and biomarker-guided interventions. Therapeutic emphasis is placed on coordinated mechanisms targeting both neurons and non-neuronal cells, such as astrocytes, microglia, and oligodendrocytes. Emerging strategies are reported to include modulation of synaptic plasticity and neurotransmission, delivery of neurotrophic factors, activation of intrinsic cytoprotective pathways (e.g., Nrf2 signaling), restoration of proteostasis, and induction of regeneration via cellular reprogramming. Glial cells are discussed as therapeutic targets involved in inflammation, metabolism, myelination, and neuronal survival. Advances in predictive, preventive, personalized, and participatory (P4) medicine, supported by genomics, multi-omics, imaging, and real-world data, are presented as accelerating biomarker discovery and enabling earlier and more precise stage-specific interventions. Future success in combating neurodegeneration will depend on integrated approaches that combine protective, supportive, and regenerative strategies, appropriate for disease stage and patient profile. By reframing neuroprotection as a systemic, multicellular endeavor, this review highlights the potential to not only extend life expectancy, but also preserve meaningful quality of life in individuals affected by neurodegenerative diseases.<\/jats:p>","DOI":"10.37349\/ent.2026.1004136","type":"journal-article","created":{"date-parts":[[2026,1,4]],"date-time":"2026-01-04T04:53:08Z","timestamp":1767502388000},"update-policy":"https:\/\/doi.org\/10.37349\/open_exploration_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Neuroprotection beyond neurons: integrated biomarker-based and astroglia- or microglia-targeted approaches to combat neurodegenerative diseases"],"prefix":"10.37349","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7362-8307","authenticated-orcid":false,"given":"Cinzia","family":"Volont\u00e9","sequence":"first","affiliation":[{"name":"National Research Council, Institute for System Analysis and Computer Science \u201cA. Ruberti\u201d, 00185 Rome, Italy; Experimental Neuroscience and Neurological Disease Models, Santa Lucia Foundation IRCCS, 00143 Rome, Italy"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4792-0416","authenticated-orcid":false,"given":"Guoku","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE 68198, USA"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4796-140X","authenticated-orcid":false,"given":"Christopher A.","family":"Shaw","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Sciences, Faculty of Medicine, University of British Columbia, Vancouver, BC V6T 1Z3, Canada"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7799-992X","authenticated-orcid":false,"suffix":"Jr.","given":"Claudio","family":"Viegas","sequence":"additional","affiliation":[{"name":"PeQuiM - Laboratory of Research in Medicinal Chemistry, Institute of Chemistry, Federal University of Alfenas, Alfenas 37133-840, MG, Brazil"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-0324-2435","authenticated-orcid":false,"given":"Joyce Alves","family":"dos Santos","sequence":"additional","affiliation":[{"name":"PeQuiM - Laboratory of Research in Medicinal Chemistry, Institute of Chemistry, Federal University of Alfenas, Alfenas 37133-840, MG, Brazil"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4258-9397","authenticated-orcid":false,"given":"Sandra H.","family":"Vaz","sequence":"additional","affiliation":[{"name":"Instituto de Farmacologia e Neuroci\u00eancias, Faculdade de Medicina, Universidade de Lisboa, 1649-028 Lisboa, Portugal; Centro Cardiovascular da Universidade de Lisboa, CCUL (CCUL@RISE), Faculdade de Medicina, Universidade de Lisboa, 1649-028 Lisboa, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9030-6115","authenticated-orcid":false,"given":"Ana M.","family":"Sebasti\u00e3o","sequence":"additional","affiliation":[{"name":"Instituto de Farmacologia e Neuroci\u00eancias, Faculdade de Medicina, Universidade de Lisboa, 1649-028 Lisboa, Portugal; Centro Cardiovascular da Universidade de Lisboa, CCUL (CCUL@RISE), Faculdade de Medicina, Universidade de Lisboa, 1649-028 Lisboa, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9564-2799","authenticated-orcid":false,"given":"Vladimir J.","family":"Balcar","sequence":"additional","affiliation":[{"name":"Neuroscience Theme, School of Medical Sciences, Faculty of Medicine and Health, The University of Sydney, Sydney NSW 2006, Australia; Laboratory of Neurobiology and Pathological Physiology, Institute of Animal Physiology and Genetics, Academy of Sciences of the Czech Republic, 602 00 Brno, Czech Republic"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1651-4212","authenticated-orcid":false,"given":"P. David","family":"Mozley","sequence":"additional","affiliation":[{"name":"Chief Medical Officer for Lutroo Imaging, LLC and Norroy North America, Ltd., Philadelphia, PA 19104, USA"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3977-6995","authenticated-orcid":false,"given":"Federico","family":"Verde","sequence":"additional","affiliation":[{"name":"Department of Neuroscience and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, 20149 Milano, Italy; Department of Pathophysiology and Transplantation, \u201cDino Ferrari\u201d Center, Universit\u00e0 degli Studi di Milano, 20122 Milano, Italy"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7698-3854","authenticated-orcid":false,"given":"Vincenzo","family":"Silani","sequence":"additional","affiliation":[{"name":"Department of Neuroscience and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, 20149 Milano, Italy; Department of Pathophysiology and Transplantation, \u201cDino Ferrari\u201d Center, Universit\u00e0 degli Studi di Milano, 20122 Milano, Italy"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3217-4166","authenticated-orcid":false,"given":"Fernanda Tibolla","family":"Viero","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Institute of Chemistry, University of S\u00e3o Paulo, Cidade Universit\u00e1ria, S\u00e3o Paulo CEP 05508-000, SP, Brazil"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2543-066X","authenticated-orcid":false,"given":"Yong","family":"Tang","sequence":"additional","affiliation":[{"name":"International Joint Research Center on Purinergic Signalling, School of Health and Rehabilitation, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, Sichuan, China; Tianfu Jincheng Laboratory, Chengdu 610212, Sichuan, China"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2114-3815","authenticated-orcid":false,"given":"Henning","family":"Ulrich","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Institute of Chemistry, University of S\u00e3o Paulo, Cidade Universit\u00e1ria, S\u00e3o Paulo CEP 05508-000, SP, Brazil; International Joint Research Center on Purinergic Signalling, School of Health and Rehabilitation, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, Sichuan, China"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2549-4919","authenticated-orcid":false,"given":"Rafael","family":"Franco","sequence":"additional","affiliation":[{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red Enfermedades Neurodegenerativas (CiberNed), National Institute of Health Carlos iii, 28031 Madrid, Spain; Departament de Biochemistry and Molecular Biomedicine, University of Barcelona, 08028 Barcelona, Spain; Institut de Qu\u00edmica Te\u00f2rica i Computacional (IQTCUB), School of Chemistry, University of Barcelona, 08028 Barcelona, Spain"}]}],"member":"21850","published-online":{"date-parts":[[2026,1,4]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-025-13130-z","article-title":"Global burden of motor neuron disease: unraveling socioeconomic disparities, aging dynamics, and divergent future trajectories (1990-2040)","volume":"272","author":"Liu","year":"2025","journal-title":"J Neurol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/S1474-4422(24)00038-3","article-title":"Collaborators G2NSD. Global, regional, and national burden of disorders affecting the nervous system, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021","volume":"23","year":"2024","journal-title":"Lancet Neurol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.parkreldis.2017.07.020","article-title":"The 200-year journey of Parkinson disease: Reflecting on the past and looking towards the future","volume":"46 Suppl 1","author":"Fahn","year":"2018","journal-title":"Parkinsonism Relat Disord"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-211-45295-0_3","article-title":"The discovery of dopamine deficiency in the parkinsonian brain","volume":"9\u201315","author":"Hornykiewicz","year":"2006","journal-title":"J Neural Transm Suppl"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph19010364","article-title":"Systematic Review on Parkinson's Disease Medications, Emphasizing on Three Recently Approved Drugs to Control Parkinson\u2019s Symptoms","volume":"19","author":"Sivanandy","year":"2021","journal-title":"Int J Environ Res Public Health"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1080\/14740338.2023.2227096","article-title":"Safety review of current pharmacotherapies for levodopa-treated patients with Parkinson\u2019s disease","volume":"22","author":"Richmond","year":"2023","journal-title":"Expert Opin Drug Saf"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1002\/mds.30151","article-title":"Exploration of Neurodegenerative Diseases Using Long-Read Sequencing and Optical Genome Mapping Technologies","volume":"40","author":"Cogan","year":"2025","journal-title":"Mov Disord"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2017.13","article-title":"Parkinson disease","volume":"3","author":"Poewe","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","article-title":"Parkinson\u2019s disease","volume":"397","author":"Bloem","year":"2021","journal-title":"Lancet"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1007\/s10787-023-01259-0","article-title":"Neuromodulation in Parkinson\u2019s disease targeting opioid and cannabinoid receptors, understanding the role of NLRP3 pathway: a novel therapeutic approach","volume":"31","author":"Alam","year":"2023","journal-title":"Inflammopharmacology"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.nbd.2009.11.004","article-title":"Neuroinflammation in Parkinson's disease: its role in neuronal death and implications for therapeutic intervention","volume":"37","author":"Tansey","year":"2010","journal-title":"Neurobiol Dis"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/S1474-4422(09)70062-6","article-title":"Neuroinflammation in Parkinson\u2019s disease: a target for neuroprotection?","volume":"8","author":"Hirsch","year":"2009","journal-title":"Lancet Neurol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/nrn.2017.62","article-title":"Non-motor features of Parkinson disease","volume":"18","author":"Schapira","year":"2017","journal-title":"Nat Rev Neurosci"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-020-0110-8","article-title":"Genetic predispositions of Parkinson\u2019s disease revealed in patient-derived brain cells","volume":"6","author":"Tran","year":"2020","journal-title":"NPJ Parkinsons Dis"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.37349\/ent.2021.00001","article-title":"Science plus technology to address challenges in determining the efficacy of neuroprotective\/neurorestorative therapies","volume":"1","author":"Franco","year":"2021","journal-title":"Explor Neuroprot Ther"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.cell.2019.09.001","article-title":"Alzheimer Disease: An Update on Pathobiology and Treatment Strategies","volume":"179","author":"Long","year":"2019","journal-title":"Cell"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/s41583-018-0113-1","article-title":"Beyond the neuron-cellular interactions early in Alzheimer disease pathogenesis","volume":"20","author":"Henstridge","year":"2019","journal-title":"Nat Rev Neurosci"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1002\/trc2.12295","article-title":"Alzheimer\u2019s disease drug development pipeline: 2022","volume":"8","author":"Cummings","year":"2022","journal-title":"Alzheimers Dement (N Y)"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1056\/NEJMoa2212948","article-title":"Lecanemab in Early Alzheimer\u2019s Disease","volume":"388","author":"van Dyck","year":"2023","journal-title":"N Engl J Med"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1038\/s41586-025-09335-x","article-title":"Lithium deficiency and the onset of Alzheimer\u2019s disease","volume":"645","author":"Aron","year":"2025","journal-title":"Nature"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"273","DOI":"10.3233\/JAD-220758","article-title":"Lithium Provides Broad Therapeutic Benefits in an Alzheimer's Disease Mouse Model","volume":"91","author":"Wiseman","year":"2023","journal-title":"J Alzheimers Dis"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0142267","article-title":"Chronic Microdose Lithium Treatment Prevented Memory Loss and Neurohistopathological Changes in a Transgenic Mouse Model of Alzheimer\u2019s Disease","volume":"10","author":"Nunes","year":"2015","journal-title":"PLoS One"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1097\/WNR.0000000000001499","article-title":"Beneficial effects of low-dose lithium on cognitive ability and pathological alteration of Alzheimer's disease transgenic mice model","volume":"31","author":"Liu","year":"2020","journal-title":"Neuroreport"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.18632\/aging.101852","article-title":"Ventral tegmental area disruption in Alzheimer's disease","volume":"11","author":"Bozzali","year":"2019","journal-title":"Aging (Albany NY)"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"985","DOI":"10.3233\/JAD-210171","article-title":"Ventral Tegmental Area Disconnection Contributes Two Years Early to Correctly Classify Patients Converted to Alzheimer's Disease: Implications for Treatment","volume":"82","author":"Serra","year":"2021","journal-title":"J Alzheimers Dis"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"181","DOI":"10.3233\/JAD-180094","article-title":"Ventral Tegmental Area in Prodromal Alzheimer\u2019s Disease: Bridging the Gap between Mice and Humans","volume":"63","author":"D\u2019Amelio","year":"2018","journal-title":"J Alzheimers Dis"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.jalz.2011.03.003","article-title":"Toward defining the preclinical stages of Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease","volume":"7","author":"Sperling","year":"2011","journal-title":"Alzheimers Dement"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.cell.2015.12.056","article-title":"The Cellular Phase of Alzheimer\u2019s Disease","volume":"164","author":"Strooper","year":"2016","journal-title":"Cell"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.cell.2017.07.023","article-title":"TREM2 Maintains Microglial Metabolic Fitness in Alzheimer\u2019s Disease","volume":"170","author":"Ulland","year":"2017","journal-title":"Cell"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1083\/jcb.201709069","article-title":"Microglia in Alzheimer\u2019s disease","volume":"217","author":"Hansen","year":"2018","journal-title":"J Cell Biol"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1016\/j.bbadis.2013.09.010","article-title":"The Alzheimer\u2019s disease mitochondrial cascade hypothesis: progress and perspectives","volume":"1842","author":"Swerdlow","year":"2014","journal-title":"Biochim Biophys Acta"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"2729","DOI":"10.1096\/fj.201700359","article-title":"Amyloid precursor protein and endosomal-lysosomal dysfunction in Alzheimer\u2019s disease: inseparable partners in a multifactorial disease","volume":"31","author":"Nixon","year":"2017","journal-title":"FASEB J"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1002\/trc2.12050","article-title":"Alzheimer\u2019s disease drug development pipeline: 2020","volume":"6","author":"Cummings","year":"2020","journal-title":"Alzheimers Dement (N Y)"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.3390\/cells14141064","article-title":"Neuroprotective Effects of Metformin Through the Modulation of Neuroinflammation and Oxidative Stress","volume":"14","author":"Reed","year":"2025","journal-title":"Cells"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3233\/BEN-2009-0226","article-title":"Fully-automated volumetric MRI with normative ranges: translation to clinical practice","volume":"21","author":"Brewer","year":"2009","journal-title":"Behav Neurol"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/S0140-6736(07)60111-1","article-title":"Huntington\u2019s disease","volume":"369","author":"Walker","year":"2007","journal-title":"Lancet"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1002\/mds.26011","article-title":"Diagnostic criteria for Huntington\u2019s disease based on natural history","volume":"29","author":"Reilmann","year":"2014","journal-title":"Mov Disord"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/S1474-4422(17)30280-6","article-title":"Therapies targeting DNA and RNA in Huntington\u2019s disease","volume":"16","author":"Wild","year":"2017","journal-title":"Lancet Neurol"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S1474-4422(10)70245-3","article-title":"Huntington\u2019s disease: from molecular pathogenesis to clinical treatment","volume":"10","author":"Ross","year":"2011","journal-title":"Lancet Neurol"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/S0072-9752(07)01256-0","article-title":"Neuropathology of Huntington\u2019s disease","volume":"89","author":"Vonsattel","year":"2008","journal-title":"Handb Clin Neurol"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/ene.13413","article-title":"Huntington\u2019s disease: a clinical review","volume":"25","author":"McColgan","year":"2018","journal-title":"Eur J Neurol"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1016\/j.neuron.2016.02.003","article-title":"The Biology of Huntingtin","volume":"89","author":"Saudou","year":"2016","journal-title":"Neuron"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.neuroscience.2011.08.052","article-title":"Pathophysiology of Huntington\u2019s disease: time-dependent alterations in synaptic and receptor function","volume":"198","author":"Raymond","year":"2011","journal-title":"Neuroscience"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3182885eb3","article-title":"Evidence-based guideline: pharmacologic treatment of chorea in Huntington disease: report of the Guideline Development Subcommittee of the American Academy of","volume":"80","author":"Suchowersky","year":"2013","journal-title":"Neurology"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1056\/NEJMoa1900907","article-title":"Targeting Huntingtin Expression in Patients with Huntington\u2019s Disease","volume":"380","author":"Tabrizi","year":"2019","journal-title":"N Engl J Med"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1172\/JCI45130","article-title":"Oligonucleotide therapeutic approaches for Huntington disease","volume":"121","author":"Sah","year":"2011","journal-title":"J Clin Invest"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1084\/jem.20080178","article-title":"A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington\u2019s disease","volume":"205","author":"Bj\u00f6rkqvist","year":"2008","journal-title":"J Exp Med"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1002\/ana.24428","article-title":"Aberrant astrocytes impair vascular reactivity in Huntington disease","volume":"78","author":"Hsiao","year":"2015","journal-title":"Ann Neurol"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.it.2015.04.007","article-title":"The choreography of neuroinflammation in Huntington\u2019s disease","volume":"36","author":"Crotti","year":"2015","journal-title":"Trends Immunol"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.cell.2006.09.015","article-title":"Transcriptional repression of PGC-1alpha by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration","volume":"127","author":"Cui","year":"2006","journal-title":"Cell"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1038\/nn.2528","article-title":"Cargo recognition failure is responsible for inefficient autophagy in Huntington\u2019s disease","volume":"13","author":"Martinez-Vicente","year":"2010","journal-title":"Nat Neurosci"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1093\/hmg\/ddr475","article-title":"Mutant huntingtin\u2019s interaction with mitochondrial protein Drp1 impairs mitochondrial biogenesis and causes defective axonal transport and synaptic degeneration in Huntington\u2019s disease","volume":"21","author":"Shirendeb","year":"2012","journal-title":"Hum Mol Genet"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph192214915","article-title":"Home-Based Exercise to Improve Motor Functions, Cognitive Functions, and Quality of Life in People with Huntington\u2019s Disease: A Systematic Review and Meta-Analysis","volume":"19","author":"Al-Wardat","year":"2022","journal-title":"Int J Environ Res Public Health"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1212\/WNL.0000000000003478","article-title":"A randomized, double-blind, placebo-controlled trial of coenzyme Q10 in Huntington disease","volume":"88","author":"McGarry","year":"2017","journal-title":"Neurology"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/S1474-4422(22)00121-1","article-title":"Potential disease-modifying therapies for Huntington\u2019s disease: lessons learned and future opportunities","volume":"21","author":"Tabrizi","year":"2022","journal-title":"Lancet Neurol"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aar3959","article-title":"Huntingtin suppression restores cognitive function in a mouse model of Huntington\u2019s disease","volume":"10","author":"Southwell","year":"2018","journal-title":"Sci Transl Med"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1002\/acn3.51438","article-title":"Digital endpoints for self-administered home-based functional assessment in pediatric Friedreich\u2019s ataxia","volume":"8","author":"Mueller","year":"2021","journal-title":"Ann Clin Transl Neurol"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/S1474-4422(17)30124-2","article-title":"Neurofilament light protein in blood as a potential biomarker of neurodegeneration in Huntington\u2019s disease: a retrospective cohort analysis","volume":"16","author":"Byrne","year":"2017","journal-title":"Lancet Neurol"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"4693","DOI":"10.1007\/s00415-024-12435-9","article-title":"Update on recent advances in amyotrophic lateral sclerosis","volume":"271","author":"Riva","year":"2024","journal-title":"J Neurol"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1097\/WCO.0000000000001294","article-title":"The genetics of amyotrophic lateral sclerosis","volume":"37","author":"Nijs","year":"2024","journal-title":"Curr Opin Neurol"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1016\/j.scitotenv.2021.152504","article-title":"Systematic and state-of the science review of the role of environmental factors in Amyotrophic Lateral Sclerosis (ALS) or Lou Gehrig\u2019s Disease","volume":"817","author":"Newell","year":"2022","journal-title":"Sci Total Environ"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1016\/j.mehy.2025.111732","article-title":"Sounding the alarm: Could stadium crowd noise contribute to amyotrophic lateral sclerosis risk in soccer and football players?","volume":"202","author":"Maggio","year":"2025","journal-title":"Med Hypotheses"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1007\/s12640-018-9980-5","article-title":"Fungal Neurotoxins and Sporadic Amyotrophic Lateral Sclerosis","volume":"35","author":"French","year":"2019","journal-title":"Neurotox Res"},{"key":"ref64","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.neures.2008.06.008","article-title":"VEGF and ALS","volume":"62","author":"Sathasivam","year":"2008","journal-title":"Neurosci Res"},{"key":"ref65","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1007\/s00415-021-10928-5","article-title":"A perspective on persistent toxicants in veterans and amyotrophic lateral sclerosis: identifying exposures determining higher ALS risk","volume":"269","author":"Re","year":"2022","journal-title":"J Neurol"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2021.117586","article-title":"Confirmation of early non-bulbar onset of amyotrophic lateral sclerosis in Spanish league soccer players","volume":"428","author":"Gamez","year":"2021","journal-title":"J Neurol Sci"},{"key":"ref67","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1080\/21678421.2020.1752250","article-title":"Increased risk and early onset of ALS in professional players from Italian Soccer Teams","volume":"21","author":"Pupillo","year":"2020","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"ref68","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1080\/21678421.2022.2127324","article-title":"Occupational history associates with ALS survival and onset segment","volume":"24","author":"Goutman","year":"2023","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"ref69","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/S1474-4422(24)00523-4","article-title":"Transforming amyotrophic lateral sclerosis into a liveable disease","volume":"24","author":"Feldman","year":"2025","journal-title":"Lancet Neurol"},{"key":"ref70","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1056\/NEJM199403033300901","article-title":"A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS\/Riluzole Study Group","volume":"330","author":"Bensimon","year":"1994","journal-title":"N Engl J Med"},{"key":"ref71","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/s0140-6736(05)64505-9","article-title":"Riluzole and amyotrophic lateral sclerosis","volume":"348","author":"Guiloff","year":"1996","journal-title":"Lancet"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-49424-3","article-title":"The preferences of people with amyotrophic lateral sclerosis on riluzole treatment in Europe","volume":"13","author":"Ludolph","year":"2023","journal-title":"Sci Rep"},{"key":"ref73","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1080\/21678421.2024.2375330","article-title":"Treatment continuity of amyotrophic lateral sclerosis with available riluzole formulations: state of the art and current challenges in a \u2018real-world\u2019 setting","volume":"26","author":"Corcia","year":"2025","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.33746","article-title":"Investigating Edaravone Use for Management of Amyotrophic Lateral Sclerosis (ALS): A Narrative Review","volume":"15","author":"Neupane","year":"2023","journal-title":"Cureus"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics16080993","article-title":"Edaravone for the Treatment of Motor Neurone Disease: A Critical Review of Approved and Alternative Formulations against a Proposed Quality Target Product Profile","volume":"16","author":"O\u2019Neill","year":"2024","journal-title":"Pharmaceutics"},{"key":"ref76","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1038\/d41573-021-00181-w","article-title":"ALS antisense drug falters in phase III","volume":"20","author":"Mullard","year":"2021","journal-title":"Nat Rev Drug Discov"},{"key":"ref77","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1080\/17582024.2024.2402216","article-title":"Tofersen for SOD1 ALS","volume":"14","author":"Everett","year":"2024","journal-title":"Neurodegener Dis Manag"},{"key":"ref78","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1002\/mus.28372","article-title":"Serious Neurologic Adverse Events in Tofersen Clinical Trials for Amyotrophic Lateral Sclerosis","volume":"71","author":"Lovett","year":"2025","journal-title":"Muscle Nerve"},{"key":"ref79","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1002\/acn3.51174","article-title":"Efficacy of Ciprofloxacin\/Celecoxib combination in zebrafish models of amyotrophic lateral sclerosis","volume":"7","author":"Goldshtein","year":"2020","journal-title":"Ann Clin Transl Neurol"},{"key":"ref80","doi-asserted-by":"publisher","DOI":"10.3390\/ph18040524","article-title":"Elucidating the Synergistic Effect of the PrimeC Combination for Amyotrophic Lateral Sclerosis in Human Induced Pluripotent Stem Cell-Derived Motor Neurons and Mouse Models","volume":"18","author":"Salomon-Zimri","year":"2025","journal-title":"Pharmaceuticals (Basel)"},{"key":"ref81","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12035-023-03554-x","article-title":"Stress-induced Neuroinflammation of the Spinal Cord is Restrained by Cort113176 (Dazucorilant), A Specific Glucocorticoid Receptor Modulator","volume":"61","author":"Meyer","year":"2024","journal-title":"Mol Neurobiol"},{"key":"ref82","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1002\/cpdd.1162","article-title":"Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Oral NLRP3 Inflammasome Inhibitor ZYIL1: First-in-Human Phase 1 Studies (Single Ascending Dose and Multiple Ascending Dose)","volume":"12","author":"Parmar","year":"2023","journal-title":"Clin Pharmacol Drug Dev"},{"key":"ref83","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1080\/21678421.2025.2515900","article-title":"A phase 2, proof-of-concept, placebo-controlled, randomized, multicenter, double-blind study to evaluate the efficacy, safety, tolerability, pharmacokinetics, and pharmacodynamics of Usnoflast (ZYIL1) in patients with amyotrophic lateral sclerosis","volume":"26","author":"Yeole","year":"2025","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"ref84","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.pharmthera.2014.09.003","article-title":"Neuroprotection for ischaemic stroke: current status and challenges","volume":"146","author":"Moretti","year":"2015","journal-title":"Pharmacol Ther"},{"key":"ref85","doi-asserted-by":"publisher","DOI":"10.31083\/JIN26495","article-title":"Effects of Motor Imagery Combined With Action Observation on Motor Function in Stroke Patients","volume":"24","author":"Nakintu","year":"2025","journal-title":"J Integr Neurosci"},{"key":"ref86","doi-asserted-by":"publisher","DOI":"10.1080\/09603123.2025.2538500","article-title":"The burden of stroke attributable to ambient particulate matter pollution in China: findings from the Global Burden of Disease Study 2021","volume":"1\u201314","author":"Wang","year":"2025","journal-title":"Int J Environ Health Res"},{"key":"ref87","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinme.2025.100493","article-title":"The health burden of chronic diseases in the United States attributable to air particulate matter","volume":"25","author":"Raina","year":"2025","journal-title":"Clin Med (Lond)"},{"key":"ref88","doi-asserted-by":"publisher","first-page":"185","DOI":"10.4415\/ANN_17_03_02","article-title":"P4 Medicine versus Hippocrates","volume":"53","author":"Pulciani","year":"2017","journal-title":"Ann Ist Super Sanita"},{"key":"ref89","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S1471489202000024","article-title":"Excitotoxicity, apoptosis and neuropsychiatric disorders","volume":"3","author":"Olney","year":"2003","journal-title":"Curr Opin Pharmacol"},{"key":"ref90","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s12028-021-01431-w","article-title":"The Critical Role of Spreading Depolarizations in Early Brain Injury: Consensus and Contention","volume":"37","author":"Andrew","year":"2022","journal-title":"Neurocrit Care"},{"key":"ref91","doi-asserted-by":"publisher","DOI":"10.1186\/s40035-021-00278-7","article-title":"Excitotoxicity, calcium and mitochondria: a triad in synaptic neurodegeneration","volume":"11","author":"Verma","year":"2022","journal-title":"Transl Neurodegener"},{"key":"ref92","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1124\/pr.109.002451","article-title":"Glutamate receptor ion channels: structure, regulation, and function","volume":"62","author":"Traynelis","year":"2010","journal-title":"Pharmacol Rev"},{"key":"ref93","doi-asserted-by":"publisher","first-page":"10681","DOI":"10.1523\/JNEUROSCI.23-33-10681.2003","article-title":"Hypoglycemic neuronal death and cognitive impairment are prevented by poly(ADP-ribose) polymerase inhibitors administered after hypoglycemia","volume":"23","author":"Suh","year":"2003","journal-title":"J Neurosci"},{"key":"ref94","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1007\/s12640-017-9753-6","article-title":"BMAA and Neurodegenerative Illness","volume":"33","author":"Cox","year":"2018","journal-title":"Neurotox Res"},{"key":"ref95","doi-asserted-by":"publisher","unstructured":"Shaw CA, Marler TE. The Lessons of ALS-PDC \u2013 Environmental Factors in ALS Etiology. Wiley-Blackwell; 2021. pp. 57\u201379.","DOI":"10.1002\/9781119745532.ch4"},{"key":"ref96","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1016\/s0140-6736(86)90468-x","article-title":"Lathyrism: evidence for role of the neuroexcitatory aminoacid BOAA","volume":"2","author":"Spencer","year":"1986","journal-title":"Lancet"},{"key":"ref97","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/ana.410380114","article-title":"Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis","volume":"38","author":"Rothstein","year":"1995","journal-title":"Ann Neurol"},{"key":"ref98","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/457079","article-title":"Kainic acid-induced neurodegenerative model: potentials and limitations","volume":"2011","author":"Zheng","year":"2011","journal-title":"J Biomed Biotechnol"},{"key":"ref99","doi-asserted-by":"publisher","DOI":"10.4103\/2152-7806.83391","article-title":"Immunoexcitotoxicity as a central mechanism in chronic traumatic encephalopathy-A unifying hypothesis","volume":"2","author":"Blaylock","year":"2011","journal-title":"Surg Neurol Int"},{"key":"ref100","doi-asserted-by":"publisher","DOI":"10.1007\/s11064-025-04454-3","article-title":"Aspartate in the Brain: A Review","volume":"50","author":"Rae","year":"2025","journal-title":"Neurochem Res"},{"key":"ref101","doi-asserted-by":"publisher","first-page":"2385","DOI":"10.1523\/JNEUROSCI.10-07-02385.1990","article-title":"Structure-activity relationships for amino acid transmitter candidates acting at N-methyl-D-aspartate and quisqualate receptors","volume":"10","author":"Patneau","year":"1990","journal-title":"J Neurosci"},{"key":"ref102","doi-asserted-by":"publisher","first-page":"3671","DOI":"10.1021\/acsptsci.4c00213","article-title":"Pharmacology, Signaling and Therapeutic Potential of Metabotropic Glutamate Receptor 5 Negative Allosteric Modulators","volume":"7","author":"Kos","year":"2024","journal-title":"ACS Pharmacol Transl Sci"},{"key":"ref103","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/S0026-895X(25)08596-7","article-title":"Metabotropic glutamate receptors negatively coupled to adenylate cyclase inhibit N-methyl-D-aspartate receptor activity and prevent neurotoxicity in mesencephalic neurons in vitro","volume":"47","author":"Ambrosini","year":"1995","journal-title":"Mol Pharmacol"},{"key":"ref104","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S0022-3565(24)34874-8","article-title":"Group II metabotropic glutamate receptor activation attenuates traumatic neuronal injury and improves neurological recovery after traumatic brain injury","volume":"290","author":"Allen","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"ref105","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1089\/neu.1997.14.885","article-title":"Neuroprotective effects of group III mGluR in traumatic neuronal injury","volume":"14","author":"Faden","year":"1997","journal-title":"J Neurotrauma"},{"key":"ref106","doi-asserted-by":"publisher","DOI":"10.1042\/AN20120044","article-title":"Metabotropic glutamate receptors inhibit microglial glutamate release","volume":"4","author":"McMullan","year":"2012","journal-title":"ASN Neuro"},{"key":"ref107","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2015.00091","article-title":"Researching glutamate - induced cytotoxicity in different cell lines: a comparative\/collective analysis\/study","volume":"9","author":"Kritis","year":"2015","journal-title":"Front Cell Neurosci"},{"key":"ref108","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2024.115050","article-title":"Modulation of GABAergic system as a therapeutic option in stroke","volume":"384","author":"Perovic","year":"2025","journal-title":"Exp Neurol"},{"key":"ref109","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2023.109600","article-title":"Adjusting the brakes to adjust neuronal activity: Adenosinergic modulation of GABAergic transmission","volume":"236","author":"Sebasti\u00e3o","year":"2023","journal-title":"Neuropharmacology"},{"key":"ref110","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1007\/s10787-021-00889-6","article-title":"Recent advances in molecular pathways and therapeutic implications targeting neuroinflammation for Alzheimer\u2019s disease","volume":"29","author":"Dhapola","year":"2021","journal-title":"Inflammopharmacology"},{"key":"ref111","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1038\/s41423-019-0223-3","article-title":"The benefits of neuroinflammation for the repair of the injured central nervous system","volume":"16","author":"Yong","year":"2019","journal-title":"Cell Mol Immunol"},{"key":"ref112","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.805657","article-title":"How Does the Immune System Enter the Brain?","volume":"13","author":"Mapunda","year":"2022","journal-title":"Front Immunol"},{"key":"ref113","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2024.1347987","article-title":"The role of neuroinflammation in neurodegenerative diseases: current understanding and future therapeutic targets","volume":"16","author":"Adamu","year":"2024","journal-title":"Front Aging Neurosci"},{"key":"ref114","doi-asserted-by":"publisher","DOI":"10.3390\/cells9071614","article-title":"Neurovascular Inflammaging in Health and Disease","volume":"9","author":"M\u00e9sz\u00e1ros","year":"2020","journal-title":"Cells"},{"key":"ref115","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci14010019","article-title":"Neuroinflammation and Neurodegenerative Diseases: How Much Do We Still Not Know?","volume":"14","author":"Balistreri","year":"2023","journal-title":"Brain Sci"},{"key":"ref116","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1111\/imm.12922","article-title":"Inflammation in CNS neurodegenerative diseases","volume":"154","author":"Stephenson","year":"2018","journal-title":"Immunology"},{"key":"ref117","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1126\/science.aat0473","article-title":"Glia as architects of central nervous system formation and function","volume":"362","author":"Allen","year":"2018","journal-title":"Science"},{"key":"ref118","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.611269","article-title":"More Than Mortar: Glia as Architects of Nervous System Development and Disease","volume":"8","author":"Lago-Baldaia","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"ref119","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/s41586-021-03950-0","article-title":"BRAIN Initiative Cell Census Network (BICCN). A multimodal cell census and atlas of the mammalian primary motor cortex","volume":"598","year":"2021","journal-title":"Nature"},{"key":"ref120","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1146\/annurev-immunol-051116-052358","article-title":"Microglia Function in the Central Nervous System During Health and Neurodegeneration","volume":"35","author":"Colonna","year":"2017","journal-title":"Annu Rev Immunol"},{"key":"ref121","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01486-5","article-title":"Role of neuroinflammation in neurodegeneration development","volume":"8","author":"Zhang","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"ref122","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1111\/bph.13139","article-title":"Microglial M1\/M2 polarization and metabolic states","volume":"173","author":"Orihuela","year":"2016","journal-title":"Br J Pharmacol"},{"key":"ref123","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.pneurobio.2015.05.003","article-title":"Alternatively activated microglia and macrophages in the central nervous system","volume":"131","author":"Franco","year":"2015","journal-title":"Prog Neurobiol"},{"key":"ref124","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1126\/science.aag2590","article-title":"How neuroinflammation contributes to neurodegeneration","volume":"353","author":"Ransohoff","year":"2016","journal-title":"Science"},{"key":"ref125","doi-asserted-by":"publisher","first-page":"3458","DOI":"10.1016\/j.neuron.2022.10.020","article-title":"Microglia states and nomenclature: A field at its crossroads","volume":"110","author":"Paolicelli","year":"2022","journal-title":"Neuron"},{"key":"ref126","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/j.cell.2017.05.018","article-title":"A Unique Microglia Type Associated with Restricting Development of Alzheimer\u2019s Disease","volume":"169","author":"Keren-Shaul","year":"2017","journal-title":"Cell"},{"key":"ref127","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.795089","article-title":"Astrocytes and Microglia in Stress-Induced Neuroinflammation: The African Perspective","volume":"13","author":"Olude","year":"2022","journal-title":"Front Immunol"},{"key":"ref128","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1038\/s41582-023-00822-1","article-title":"Functional roles of reactive astrocytes in neuroinflammation and neurodegeneration","volume":"19","author":"Patani","year":"2023","journal-title":"Nat Rev Neurol"},{"key":"ref129","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1038\/nn.4043","article-title":"Diversity of astrocyte functions and phenotypes in neural circuits","volume":"18","author":"Khakh","year":"2015","journal-title":"Nat Neurosci"},{"key":"ref130","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1007\/s00429-017-1383-5","article-title":"Human astrocytes: structure and functions in the healthy brain","volume":"222","author":"Vasile","year":"2017","journal-title":"Brain Struct Funct"},{"key":"ref131","doi-asserted-by":"publisher","first-page":"2583","DOI":"10.1007\/s11064-015-1581-6","article-title":"The Glymphatic System: A Beginner\u2019s Guide","volume":"40","author":"Jessen","year":"2015","journal-title":"Neurochem Res"},{"key":"ref132","doi-asserted-by":"publisher","first-page":"10246","DOI":"10.1007\/s12035-024-04210-8","article-title":"Transcriptome Analysis Reveals Dynamic Microglial-Induced A1 Astrocyte Reactivity via C3\/C3aR\/NF-\u03baB Signaling After Ischemic Stroke","volume":"61","author":"Wang","year":"2024","journal-title":"Mol Neurobiol"},{"key":"ref133","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuint.2021.105080","article-title":"A1\/A2 astrocytes in central nervous system injuries and diseases: Angels or devils?","volume":"148","author":"Fan","year":"2021","journal-title":"Neurochem Int"},{"key":"ref134","doi-asserted-by":"publisher","DOI":"10.3390\/antiox8080265","article-title":"Astrocytic Oxidative\/Nitrosative Stress Contributes to Parkinson\u2019s Disease Pathogenesis: The Dual Role of Reactive Astrocytes","volume":"8","author":"Rizor","year":"2019","journal-title":"Antioxidants (Basel)"},{"key":"ref135","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1515\/bmc-2016-0029","article-title":"Alzheimer\u2019s disease as an inflammatory disease","volume":"8","author":"Bol\u00f3s","year":"2017","journal-title":"Biomol Concepts"},{"key":"ref136","doi-asserted-by":"publisher","first-page":"151","DOI":"10.37349\/ent.2023.00044","article-title":"Looking at the periphery\u2014new hypothesis to look for new targets for Alzheimer\u2019s disease therapy","volume":"3","author":"Avila","year":"2023","journal-title":"Explor Neuroprot Ther"},{"key":"ref137","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.neulet.2017.02.007","article-title":"Alterations of myelin morphology and oligodendrocyte development in early stage of Alzheimer\u2019s disease mouse model","volume":"642","author":"Wu","year":"2017","journal-title":"Neurosci Lett"},{"key":"ref138","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1038\/s41593-022-01104-7","article-title":"A shared disease-associated oligodendrocyte signature among multiple CNS pathologies","volume":"25","author":"Kenigsbuch","year":"2022","journal-title":"Nat Neurosci"},{"key":"ref139","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1038\/s41586-018-0842-3","article-title":"Dynamics of oligodendrocyte generation in multiple sclerosis","volume":"566","author":"Yeung","year":"2019","journal-title":"Nature"},{"key":"ref140","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2024.1375330","article-title":"Oligodendrocytes in amyotrophic lateral sclerosis and frontotemporal dementia: the new players on stage","volume":"17","author":"Jamet","year":"2024","journal-title":"Front Mol Neurosci"},{"key":"ref141","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/j.it.2021.07.002","article-title":"The tetraspan MS4A family in homeostasis, immunity, and disease","volume":"42","author":"Mattiola","year":"2021","journal-title":"Trends Immunol"},{"key":"ref142","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.arr.2014.11.003","article-title":"DAMPs and neurodegeneration","volume":"24","author":"Thundyil","year":"2015","journal-title":"Ageing Res Rev"},{"key":"ref143","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21239188","article-title":"Glia in Neurodegeneration: The Housekeeper, the Defender and the Perpetrator","volume":"21","author":"Sheeler","year":"2020","journal-title":"Int J Mol Sci"},{"key":"ref144","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.neuroscience.2018.04.003","article-title":"Cell-to-cell Communication by Extracellular Vesicles: Focus on Microglia","volume":"405","author":"Paolicelli","year":"2019","journal-title":"Neuroscience"},{"key":"ref145","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2017.00910","article-title":"ATP Modifies the Proteome of Extracellular Vesicles Released by Microglia and Influences Their Action on Astrocytes","volume":"8","author":"Drago","year":"2017","journal-title":"Front Pharmacol"},{"key":"ref146","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1038\/s41591-018-0051-5","article-title":"Block of A1 astrocyte conversion by microglia is neuroprotective in models of Parkinson's disease","volume":"24","author":"Yun","year":"2018","journal-title":"Nat Med"},{"key":"ref147","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-021-02158-3","article-title":"Crosstalk between astrocytes and microglia results in increased degradation of \u03b1-synuclein and amyloid-\u03b2 aggregates","volume":"18","author":"Rostami","year":"2021","journal-title":"J Neuroinflammation"},{"key":"ref148","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1248\/bpb.27.961","article-title":"Neuronal apoptosis and protection: effects of nitric oxide and endoplasmic reticulum-related proteins","volume":"27","author":"Nomura","year":"2004","journal-title":"Biol Pharm Bull"},{"key":"ref149","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1126\/science.abp9556","article-title":"MEG3 activates necroptosis in human neuron xenografts modeling Alzheimer's disease","volume":"381","author":"Balusu","year":"2023","journal-title":"Science"},{"key":"ref150","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1111\/imr.12534","article-title":"Molecular mechanisms and functions of pyroptosis, inflammatory caspases and inflammasomes in infectious diseases","volume":"277","author":"Man","year":"2017","journal-title":"Immunol Rev"},{"key":"ref151","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/nature25158","article-title":"Microglia-derived ASC specks cross-seed amyloid-\u03b2 in Alzheimer\u2019s disease","volume":"552","author":"Venegas","year":"2017","journal-title":"Nature"},{"key":"ref152","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.intimp.2018.12.019","article-title":"The mechanisms of NLRP3 inflammasome\/pyroptosis activation and their role in Parkinson\u2019s disease","volume":"67","author":"Wang","year":"2019","journal-title":"Int Immunopharmacol"},{"key":"ref153","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2021.167379","article-title":"Pyroptosis, and its Role in Central Nervous System Disease","volume":"434","author":"Hu","year":"2022","journal-title":"J Mol Biol"},{"key":"ref154","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2025.149861","article-title":"Alzheimer\u2019s disease: a jigsaw puzzle comprised of different types of programmed cell death pieces","volume":"1865","author":"Wang","year":"2025","journal-title":"Brain Res"},{"key":"ref155","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/j.tins.2025.06.008","article-title":"Triggering ferroptosis in neurodegenerative diseases","volume":"48","author":"Nguyen","year":"2025","journal-title":"Trends Neurosci"},{"key":"ref156","doi-asserted-by":"publisher","DOI":"10.3390\/cells11182908","article-title":"Neuroinflammation and Parkinson's Disease-From Neurodegeneration to Therapeutic Opportunities","volume":"11","author":"Ara\u00fajo","year":"2022","journal-title":"Cells"},{"key":"ref157","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2021.114477","article-title":"Biomarkers of Oxidative Stress and Antioxidant Defense","volume":"209","author":"Demirci-\u00c7eki\u00e7","year":"2022","journal-title":"J Pharm Biomed Anal"},{"key":"ref158","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1124\/jpet.116.237503","article-title":"Oxidative Stress and the Central Nervous System","volume":"360","author":"Salim","year":"2017","journal-title":"J Pharmacol Exp Ther"},{"key":"ref159","doi-asserted-by":"publisher","DOI":"10.3390\/molecules24081583","article-title":"Oxidative Stress: A Key Modulator in Neurodegenerative Diseases","volume":"24","author":"Singh","year":"2019","journal-title":"Molecules"},{"key":"ref160","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s11064-020-03208-7","article-title":"Reactive Oxygen Species: Beyond Their Reactive Behavior","volume":"46","author":"Tauffenberger","year":"2021","journal-title":"Neurochem Res"},{"key":"ref161","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1007\/s00018-011-0682-x","article-title":"Highly reactive oxygen species: detection, formation, and possible functions","volume":"68","author":"Freinbichler","year":"2011","journal-title":"Cell Mol Life Sci"},{"key":"ref162","doi-asserted-by":"publisher","DOI":"10.3390\/antiox8080285","article-title":"Physiologic Implications of Reactive Oxygen Species Production by Mitochondrial Complex I Reverse Electron Transport","volume":"8","author":"Onukwufor","year":"2019","journal-title":"Antioxidants (Basel)"},{"key":"ref163","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s12291-014-0446-0","article-title":"Free radicals: properties, sources, targets, and their implication in various diseases","volume":"30","author":"Phaniendra","year":"2015","journal-title":"Indian J Clin Biochem"},{"key":"ref164","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.freeradbiomed.2014.07.046","article-title":"Nox family NADPH oxidases: Molecular mechanisms of activation","volume":"76","author":"Brandes","year":"2014","journal-title":"Free Radic Biol Med"},{"key":"ref165","doi-asserted-by":"publisher","DOI":"10.3390\/cells10020233","article-title":"Intracellular Sources of ROS\/H","volume":"10","author":"Konno","year":"2021","journal-title":"Cells"},{"key":"ref166","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s00705-016-3130-2","article-title":"Roles of reactive oxygen species in cell signaling pathways and immune responses to viral infections","volume":"162","author":"Li","year":"2017","journal-title":"Arch Virol"},{"key":"ref167","doi-asserted-by":"publisher","first-page":"5839","DOI":"10.1073\/pnas.1804932115","article-title":"Oxygen radicals, nitric oxide, and peroxynitrite: Redox pathways in molecular medicine","volume":"115","author":"Radi","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref168","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1093\/molehr\/gaw043","article-title":"P66Shc, a key regulator of metabolism and mitochondrial ROS production, is dysregulated by mouse embryo culture","volume":"22","author":"Edwards","year":"2016","journal-title":"Mol Hum Reprod"},{"key":"ref169","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/8416763","article-title":"Oxidative Stress: Harms and Benefits for Human Health","volume":"2017","author":"Pizzino","year":"2017","journal-title":"Oxid Med Cell Longev"},{"key":"ref170","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222413384","article-title":"Mitochondrial Oxidative Stress-A Causative Factor and Therapeutic Target in Many Diseases","volume":"22","author":"Kowalczyk","year":"2021","journal-title":"Int J Mol Sci"},{"key":"ref171","doi-asserted-by":"publisher","first-page":"E4966","DOI":"10.1073\/pnas.1603244113","article-title":"Peroxidation of polyunsaturated fatty acids by lipoxygenases drives ferroptosis","volume":"113","author":"Yang","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref172","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2020.101049","article-title":"Brain lipid peroxidation and alzheimer disease: Synergy between the Butterfield and Mattson laboratories","volume":"64","author":"Butterfield","year":"2020","journal-title":"Ageing Res Rev"},{"key":"ref173","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/S1474-4422(14)70117-6","article-title":"The role of iron in brain ageing and neurodegenerative disorders","volume":"13","author":"Ward","year":"2014","journal-title":"Lancet Neurol"},{"key":"ref174","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2019.00180","article-title":"Iron in Neurodegeneration - Cause or Consequence?","volume":"13","author":"Ndayisaba","year":"2019","journal-title":"Front Neurosci"},{"key":"ref175","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.freeradbiomed.2016.06.027","article-title":"Adaptive regulation of the brain\u2019s antioxidant defences by neurons and astrocytes","volume":"100","author":"Baxter","year":"2016","journal-title":"Free Radic Biol Med"},{"key":"ref176","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1089\/ars.2016.6925","article-title":"Redox Signaling Mediated by Thioredoxin and Glutathione Systems in the Central Nervous System","volume":"27","author":"Ren","year":"2017","journal-title":"Antioxid Redox Signal"},{"key":"ref177","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/ncb2897","article-title":"Causes and consequences of replication stress","volume":"16","author":"Zeman","year":"2014","journal-title":"Nat Cell Biol"},{"key":"ref178","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20246136","article-title":"Oxidative Damage of DNA as Early Marker of Alzheimer\u2019s Disease","volume":"20","author":"Pe\u00f1a-Bautista","year":"2019","journal-title":"Int J Mol Sci"},{"key":"ref179","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1038\/nrn4020","article-title":"Genomic integrity and the ageing brain","volume":"16","author":"Chow","year":"2015","journal-title":"Nat Rev Neurosci"},{"key":"ref180","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1007\/s10522-023-10050-1","article-title":"Aging, oxidative stress and degenerative diseases: mechanisms, complications and emerging therapeutic strategies","volume":"24","author":"Chaudhary","year":"2023","journal-title":"Biogerontology"},{"key":"ref181","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.33549\/physiolres.933403","article-title":"Nrf2 as a key player of redox regulation in cardiovascular diseases","volume":"65 Suppl 1","author":"Baran\u010d\u00edk","year":"2016","journal-title":"Physiol Res"},{"key":"ref182","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.pharmthera.2015.11.003","article-title":"Nrf2-ARE pathway: An emerging target against oxidative stress and neuroinflammation in neurodegenerative diseases","volume":"157","author":"Buendia","year":"2016","journal-title":"Pharmacol Ther"},{"key":"ref183","doi-asserted-by":"publisher","DOI":"10.3390\/molecules23071803","article-title":"The Keap1\/Nrf2-ARE Pathway as a Pharmacological Target for Chalcones","volume":"23","author":"de Freitas Silva","year":"2018","journal-title":"Molecules"},{"key":"ref184","doi-asserted-by":"publisher","DOI":"10.3390\/antiox8020046","article-title":"Antioxidant Defense Mechanisms in Erythrocytes and in the Central Nervous System","volume":"8","author":"Franco","year":"2019","journal-title":"Antioxidants (Basel)"},{"key":"ref185","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23115938","article-title":"An Overview of Oxidative Stress, Neuroinflammation, and Neurodegenerative Diseases","volume":"23","author":"Teleanu","year":"2022","journal-title":"Int J Mol Sci"},{"key":"ref186","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1007\/BF00343235","article-title":"The L-dihydroxyphenylalanine (L-DOPA) effect in Parkinson's syndrome in man: On the pathogenesis and treatment of Parkinson akinesis","volume":"203","author":"Birkmayer","year":"1962","journal-title":"Arch Psychiatr Nervenkr Z Gesamte Neurol Psychiatr"},{"key":"ref187","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1126\/science.aam9080","article-title":"Dopamine oxidation mediates mitochondrial and lysosomal dysfunction in Parkinson\u2019s disease","volume":"357","author":"Burbulla","year":"2017","journal-title":"Science"},{"key":"ref188","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/5497046","article-title":"Proteostasis Failure in Neurodegenerative Diseases: Focus on Oxidative Stress","volume":"2020","author":"H\u00f6hn","year":"2020","journal-title":"Oxid Med Cell Longev"},{"key":"ref189","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3233\/JPD-201981","article-title":"Mitochondria and Parkinson\u2019s Disease: Clinical, Molecular, and Translational Aspects","volume":"11","author":"Borsche","year":"2021","journal-title":"J Parkinsons Dis"},{"key":"ref190","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2019.104671","article-title":"Modifiable risk and protective factors in disease development, progression and clinical subtypes of Parkinson\u2019s disease: What do prospective studies suggest?","volume":"134","author":"Belvisi","year":"2020","journal-title":"Neurobiol Dis"},{"key":"ref191","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctim.2019.102294","article-title":"Oxidative stress in alzheimer\u2019s disease: A review on emergent natural polyphenolic therapeutics","volume":"49","author":"Cassidy","year":"2020","journal-title":"Complement Ther Med"},{"key":"ref192","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/s41583-019-0132-6","article-title":"Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease","volume":"20","author":"Butterfield","year":"2019","journal-title":"Nat Rev Neurosci"},{"key":"ref193","doi-asserted-by":"publisher","first-page":"2491","DOI":"10.1007\/s00204-019-02538-y","article-title":"Management of oxidative stress and other pathologies in Alzheimer\u2019s disease","volume":"93","author":"Simunkova","year":"2019","journal-title":"Arch Toxicol"},{"key":"ref194","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.bbrc.2009.02.136","article-title":"A novel approach to the identification and quantitative elemental analysis of amyloid deposits--insights into the pathology of Alzheimer\u2019s disease","volume":"382","author":"Rajendran","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"key":"ref195","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20133297","article-title":"Lessons on Differential Neuronal-Death-Vulnerability from Familial Cases of Parkinson\u2019s and Alzheimer\u2019s Diseases","volume":"20","author":"Franco","year":"2019","journal-title":"Int J Mol Sci"},{"key":"ref196","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2018.00329","article-title":"A Mitochondria-Associated Oxidative Stress Perspective on Huntington's Disease","volume":"11","author":"Zheng","year":"2018","journal-title":"Front Mol Neurosci"},{"key":"ref197","doi-asserted-by":"publisher","first-page":"2944","DOI":"10.1007\/s12035-015-9188-0","article-title":"Mutant Huntingtin and Elusive Defects in Oxidative Metabolism and Mitochondrial Calcium Handling","volume":"53","author":"Brustovetsky","year":"2016","journal-title":"Mol Neurobiol"},{"key":"ref198","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23169339","article-title":"Oxidative Stress in Amyotrophic Lateral Sclerosis: Synergy of Genetic and Environmental Factors","volume":"23","author":"Motataianu","year":"2022","journal-title":"Int J Mol Sci"},{"key":"ref199","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20153685","article-title":"Partial Failure of Proteostasis Systems Counteracting TDP-43 Aggregates in Neurodegenerative Diseases","volume":"20","author":"Cascella","year":"2019","journal-title":"Int J Mol Sci"},{"key":"ref200","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1038\/s41593-018-0234-x","article-title":"The role of brain vasculature in neurodegenerative disorders","volume":"21","author":"Sweeney","year":"2018","journal-title":"Nat Neurosci"},{"key":"ref201","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1021\/acsptsci.0c00217","article-title":"Extending the Calpain-Cathepsin Hypothesis to the Neurovasculature: Protection of Brain Endothelial Cells and Mice from Neurotrauma","volume":"4","author":"Knopp","year":"2021","journal-title":"ACS Pharmacol Transl Sci"},{"key":"ref202","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.cell.2022.12.032","article-title":"Wilson DM 3rd, Cookson MR, Van Den Bosch L, Zetterberg H, Holtzman DM, Dewachter I. Hallmarks of neurodegenerative diseases","volume":"186","year":"2023","journal-title":"Cell"},{"key":"ref203","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1152\/physrev.00014.2003","article-title":"Long-term potentiation and memory","volume":"84","author":"Lynch","year":"2004","journal-title":"Physiol Rev"},{"key":"ref204","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.arr.2016.04.005","article-title":"Synaptic pathology: A shared mechanism in neurological disease","volume":"28","author":"Henstridge","year":"2016","journal-title":"Ageing Res Rev"},{"key":"ref205","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/s0896-6273(03)00640-8","article-title":"AMPA receptor trafficking at excitatory synapses","volume":"40","author":"Bredt","year":"2003","journal-title":"Neuron"},{"key":"ref206","doi-asserted-by":"publisher","first-page":"2816","DOI":"10.1016\/j.drudis.2021.07.027","article-title":"Positive AMPA receptor modulation in the treatment of neuropsychiatric disorders: A long and winding road","volume":"26","author":"Kadriu","year":"2021","journal-title":"Drug Discov Today"},{"key":"ref207","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1523\/JNEUROSCI.20-01-00008.2000","article-title":"Positive modulation of AMPA receptors increases neurotrophin expression by hippocampal and cortical neurons","volume":"20","author":"Lauterborn","year":"2000","journal-title":"J Neurosci"},{"key":"ref208","doi-asserted-by":"publisher","first-page":"2897","DOI":"10.1152\/jn.00287.2010","article-title":"NMDA receptor activation enhances inhibitory GABAergic transmission onto hippocampal pyramidal neurons via presynaptic and postsynaptic mechanisms","volume":"105","author":"Xue","year":"2011","journal-title":"J Neurophysiol"},{"key":"ref209","doi-asserted-by":"publisher","first-page":"3129","DOI":"10.1038\/s41401-025-01576-w","article-title":"Molecular mechanisms of excitotoxicity and their relevance to the pathogenesis of neurodegenerative diseases-an update","volume":"46","author":"Wu","year":"2025","journal-title":"Acta Pharmacol Sin"},{"key":"ref210","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/aps.2009.24","article-title":"Molecular mechanisms of excitotoxicity and their relevance to pathogenesis of neurodegenerative diseases","volume":"30","author":"Dong","year":"2009","journal-title":"Acta Pharmacol Sin"},{"key":"ref211","doi-asserted-by":"publisher","first-page":"4537","DOI":"10.1007\/s12035-016-9995-y","article-title":"Heteroreceptor Complexes Formed by Dopamine D","volume":"54","author":"Rodr\u00edguez-Ruiz","year":"2017","journal-title":"Mol Neurobiol"},{"key":"ref212","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0130993","article-title":"The Effects of Anti-Dementia and Nootropic Treatments on the Mortality of Patients with Dementia: A Population-Based Cohort Study in Taiwan","volume":"10","author":"Wu","year":"2015","journal-title":"PLoS One"},{"key":"ref213","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.3233\/JAD-160763","article-title":"Role of Glutamate and NMDA Receptors in Alzheimer\u2019s Disease","volume":"57","author":"Wang","year":"2017","journal-title":"J Alzheimers Dis"},{"key":"ref214","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1080\/1061186X.2018.1474361","article-title":"Drug development for Alzheimer\u2019s disease: review","volume":"27","author":"Lao","year":"2019","journal-title":"J Drug Target"},{"key":"ref215","doi-asserted-by":"publisher","DOI":"10.3389\/fragi.2024.1480932","article-title":"DNA methylation, histone acetylation in the regulation of memory and its modulation during aging","volume":"5","author":"Singh","year":"2025","journal-title":"Front Aging"},{"key":"ref216","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/6690523","article-title":"The Histone Modifications of Neuronal Plasticity","volume":"2021","author":"Geng","year":"2021","journal-title":"Neural Plast"},{"key":"ref217","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.1444","article-title":"Intermittent fasting increases adult hippocampal neurogenesis","volume":"10","author":"Baik","year":"2020","journal-title":"Brain Behav"},{"key":"ref218","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.15092","article-title":"Exercise promotes the expression of brain derived neurotrophic factor (BDNF) through the action of the ketone body \u03b2-hydroxybutyrate","volume":"5","author":"Sleiman","year":"2016","journal-title":"Elife"},{"key":"ref219","doi-asserted-by":"publisher","DOI":"10.3390\/nu13093166","article-title":"The Effects of Intermittent Fasting on Brain and Cognitive Function","volume":"13","author":"Gudden","year":"2021","journal-title":"Nutrients"},{"key":"ref220","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci12070929","article-title":"Evidence of Neuroplastic Changes after Transcranial Magnetic, Electric, and Deep Brain Stimulation","volume":"12","author":"Kricheldorff","year":"2022","journal-title":"Brain Sci"},{"key":"ref221","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurot.2024.e00330","article-title":"Neuromodulation techniques - From non-invasive brain stimulation to deep brain stimulation","volume":"21","author":"Davidson","year":"2024","journal-title":"Neurotherapeutics"},{"key":"ref222","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1097\/HTR.0b013e318217df55","article-title":"Noninvasive brain stimulation in traumatic brain injury","volume":"27","author":"Demirtas-Tatlidede","year":"2012","journal-title":"J Head Trauma Rehabil"},{"key":"ref223","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci12070890","article-title":"The Neuromodulatory Role of the Noradrenergic and Cholinergic Systems and Their Interplay in Cognitive Functions: A Focused Review","volume":"12","author":"Slater","year":"2022","journal-title":"Brain Sci"},{"key":"ref224","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1093\/brain\/awy132","article-title":"The cholinergic system in the pathophysiology and treatment of Alzheimer\u2019s disease","volume":"141","author":"Hampel","year":"2018","journal-title":"Brain"},{"key":"ref225","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1001\/archneur.1997.00550160091022","article-title":"Effects of xanomeline, a selective muscarinic receptor agonist, on cognitive function and behavioral symptoms in Alzheimer disease","volume":"54","author":"Bodick","year":"1997","journal-title":"Arch Neurol"},{"key":"ref226","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1176\/appi.ajp.21101083","article-title":"Muscarinic Acetylcholine Receptor Agonists as Novel Treatments for Schizophrenia","volume":"179","author":"Paul","year":"2022","journal-title":"Am J Psychiatry"},{"key":"ref227","unstructured":"Singh R, Sadiq NM. Cholinesterase Inhibitors"},{"key":"ref228","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/j.neuron.2015.12.029","article-title":"Dopamine Does Double Duty in Motivating Cognitive Effort","volume":"89","author":"Westbrook","year":"2016","journal-title":"Neuron"},{"key":"ref229","doi-asserted-by":"publisher","DOI":"10.3389\/fncir.2017.00108","article-title":"Neuromodulatory Systems and Their Interactions: A Review of Models, Theories, and Experiments","volume":"11","author":"Avery","year":"2017","journal-title":"Front Neural Circuits"},{"key":"ref230","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2019.00363","article-title":"Brain-Derived Neurotrophic Factor: A Key Molecule for Memory in the Healthy and the Pathological Brain","volume":"13","author":"Miranda","year":"2019","journal-title":"Front Cell Neurosci"},{"key":"ref231","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.5114\/aoms.2015.56342","article-title":"Brain-derived neurotrophic factor and its clinical implications","volume":"11","author":"Bathina","year":"2015","journal-title":"Arch Med Sci"},{"key":"ref232","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2020.105281","article-title":"Challenges of BDNF-based therapies: From common to rare diseases","volume":"162","author":"Miranda-Louren\u00e7o","year":"2020","journal-title":"Pharmacol Res"},{"key":"ref233","doi-asserted-by":"publisher","first-page":"3372","DOI":"10.1016\/j.ymthe.2024.08.022","article-title":"A small TAT-TrkB peptide prevents BDNF receptor cleavage and restores synaptic physiology in Alzheimer\u2019s disease","volume":"32","author":"Fonseca-Gomes","year":"2024","journal-title":"Mol Ther"},{"key":"ref234","doi-asserted-by":"publisher","DOI":"10.3389\/fnana.2017.00029","article-title":"Glial Cell Line-Derived Neurotrophic Factor Gene Delivery in Parkinson\u2019s Disease: A Delicate Balance between Neuroprotection, Trophic Effects, and Unwanted Compensatory Mechanisms","volume":"11","author":"Tenenbaum","year":"2017","journal-title":"Front Neuroanat"},{"key":"ref235","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1002\/mds.27943","article-title":"Glial cell line-derived neurotrophic factor receptor Rearranged during transfection agonist supports dopamine neurons in Vitro and enhances dopamine release In Vivo","volume":"35","author":"Mahato","year":"2020","journal-title":"Mov Disord"},{"key":"ref236","doi-asserted-by":"publisher","first-page":"P35","DOI":"10.1007\/pl00007744","article-title":"Glial cell line-derived neurotrophic factor (GDNF): a drug candidate for the treatment of Parkinson\u2019s disease","volume":"245","author":"Grondin","year":"1998","journal-title":"J Neurol"},{"key":"ref237","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-019-1429-0","article-title":"Mesencephalic astrocyte-derived neurotrophic factor (MANF) protects against A\u03b2 toxicity via attenuating A\u03b2-induced endoplasmic reticulum stress","volume":"16","author":"Xu","year":"2019","journal-title":"J Neuroinflammation"},{"key":"ref238","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2019.00765","article-title":"Mesencephalic Astrocyte-Derived Neurotrophic Factor (MANF) Is Highly Expressed in Mouse Tissues With Metabolic Function","volume":"10","author":"Danilova","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref239","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2019.00533","article-title":"Nerve Growth Factor Pathobiology During the Progression of Alzheimer\u2019s Disease","volume":"13","author":"Mufson","year":"2019","journal-title":"Front Neurosci"},{"key":"ref240","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1007\/s12975-015-0409-7","article-title":"Intranasal Insulin and Insulin-Like Growth Factor 1 as Neuroprotectants in Acute Ischemic Stroke","volume":"6","author":"Lioutas","year":"2015","journal-title":"Transl Stroke Res"},{"key":"ref241","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1007\/s11481-019-09873-y","article-title":"Strategies for the use of Extracellular Vesicles for the Delivery of Therapeutics","volume":"15","author":"Sil","year":"2020","journal-title":"J Neuroimmune Pharmacol"},{"key":"ref242","doi-asserted-by":"publisher","DOI":"10.37349\/ent.2025.1004104","article-title":"Advancements in extracellular vesicle therapy for neurodegenerative diseases","volume":"5","author":"Hu","year":"2025","journal-title":"Explor Neuroprotective Ther"},{"key":"ref243","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1089\/hum.2010.190","article-title":"Adeno-associated virus liver transduction efficiency measured by in vivo [18F]FHBG positron emission tomography imaging in rodents and nonhuman primates","volume":"22","author":"Pa\u00f1eda","year":"2011","journal-title":"Hum Gene Ther"},{"key":"ref244","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22126389","article-title":"Adeno-Associated Viral Vectors as Versatile Tools for Parkinson\u2019s Research, Both for Disease Modeling Purposes and for Therapeutic Uses","volume":"22","author":"Fajardo-Serrano","year":"2021","journal-title":"Int J Mol Sci"},{"key":"ref245","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.nut.2012.11.007","article-title":"Effects of olive polyphenols administration on nerve growth factor and brain-derived neurotrophic factor in the mouse brain","volume":"29","author":"Nicol\u00f3","year":"2013","journal-title":"Nutrition"},{"key":"ref246","doi-asserted-by":"publisher","DOI":"10.3390\/molecules30122657","article-title":"Brain Neurotrophins and Plant Polyphenols: A Powerful Connection","volume":"30","author":"Fiore","year":"2025","journal-title":"Molecules"},{"key":"ref247","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1080\/1028415X.2020.1865758","article-title":"Effects of nutritional interventions on BDNF concentrations in humans: a systematic review","volume":"25","author":"Gravesteijn","year":"2022","journal-title":"Nutr Neurosci"},{"key":"ref248","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-023-00692-7","article-title":"Amyloid-\u03b2 specific regulatory T cells attenuate Alzheimer\u2019s disease pathobiology in APP\/PS1 mice","volume":"18","author":"Yeapuri","year":"2023","journal-title":"Mol Neurodegener"},{"key":"ref249","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-020-00375-7","article-title":"Harnessing regulatory T cell neuroprotective activities for treatment of neurodegenerative disorders","volume":"15","author":"Machhi","year":"2020","journal-title":"Mol Neurodegener"},{"key":"ref250","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1189\/jlb.0507296","article-title":"Neuroprotective activities of CD4+CD25+ regulatory T cells in an animal model of Parkinson\u2019s disease","volume":"82","author":"Reynolds","year":"2007","journal-title":"J Leukoc Biol"},{"key":"ref251","doi-asserted-by":"publisher","first-page":"218","DOI":"10.2174\/157488912803252023","article-title":"The Nrf2-ARE pathway: a valuable therapeutic target for the treatment of neurodegenerative diseases","volume":"7","author":"Joshi","year":"2012","journal-title":"Recent Pat CNS Drug Discov"},{"key":"ref252","doi-asserted-by":"publisher","first-page":"3576","DOI":"10.1111\/febs.14379","article-title":"The role of Nrf2 signaling in counteracting neurodegenerative diseases","volume":"285","author":"Dinkova-Kostova","year":"2018","journal-title":"FEBS J"},{"key":"ref253","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1152\/physrev.00022.2011","article-title":"Sirtuin 1 and sirtuin 3: physiological modulators of metabolism","volume":"92","author":"Nogueiras","year":"2012","journal-title":"Physiol Rev"},{"key":"ref254","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-022-01257-8","article-title":"The sirtuin family in health and disease","volume":"7","author":"Wu","year":"2022","journal-title":"Signal Transduct Target Ther"},{"key":"ref255","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2023.101936","article-title":"Sirtuins, resveratrol and the intertwining cellular pathways connecting them","volume":"88","author":"Ungurianu","year":"2023","journal-title":"Ageing Res Rev"},{"key":"ref256","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-022-00966-4","article-title":"Targeted protein degradation: mechanisms, strategies and application","volume":"7","author":"Zhao","year":"2022","journal-title":"Signal Transduct Target Ther"},{"key":"ref257","doi-asserted-by":"publisher","first-page":"2245","DOI":"10.18632\/aging.101319","article-title":"Towards natural mimetics of metformin and rapamycin","volume":"9","author":"Aliper","year":"2017","journal-title":"Aging (Albany NY)"},{"key":"ref258","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.biopsych.2021.06.009","article-title":"Astrocyte-Derived Extracellular Vesicle-Mediated Activation of Primary Ciliary Signaling Contributes to the Development of Morphine Tolerance","volume":"90","author":"Ma","year":"2021","journal-title":"Biol Psychiatry"},{"key":"ref259","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2021.105607","article-title":"Primary cilia and ciliary signaling pathways in aging and age-related brain disorders","volume":"163","author":"Ma","year":"2022","journal-title":"Neurobiol Dis"},{"key":"ref260","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1038\/ncb2117","article-title":"Primary cilia regulate mTORC1 activity and cell size through Lkb1","volume":"12","author":"Boehlke","year":"2010","journal-title":"Nat Cell Biol"},{"key":"ref261","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/nrneurol.2013.247","article-title":"Primary cilia in neurodevelopmental disorders","volume":"10","author":"Valente","year":"2014","journal-title":"Nat Rev Neurol"},{"key":"ref262","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1016\/j.biopsych.2023.11.004","article-title":"Cilia and Extracellular Vesicles in Brain Development and Disease","volume":"95","author":"Ma","year":"2024","journal-title":"Biol Psychiatry"},{"key":"ref263","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1016\/j.ymthe.2023.03.030","article-title":"Extracellular vesicle-mediated delivery of anti-miR-106b inhibits morphine-induced primary ciliogenesis in the brain","volume":"31","author":"Ma","year":"2023","journal-title":"Mol Ther"},{"key":"ref264","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2023.1232188","article-title":"Recent advances in the understanding of cilia mechanisms and their applications as therapeutic targets","volume":"10","author":"Saito","year":"2023","journal-title":"Front Mol Biosci"},{"key":"ref265","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-32229-9","article-title":"Primary cilia and SHH signaling impairments in human and mouse models of Parkinson\u2019s disease","volume":"13","author":"Schmidt","year":"2022","journal-title":"Nat Commun"},{"key":"ref266","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.tcb.2024.10.014","article-title":"Roles for primary cilia in synapses and neurological disorders","volume":"35","author":"Volos","year":"2025","journal-title":"Trends Cell Biol"},{"key":"ref267","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.4103\/1673-5374.165496","article-title":"PTEN inhibition and axon regeneration and neural repair","volume":"10","author":"Ohtake","year":"2015","journal-title":"Neural Regen Res"},{"key":"ref268","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2016.00486","article-title":"Intrinsic Axonal Growth and the Drive for Regeneration","volume":"10","author":"O\u2019Donovan","year":"2016","journal-title":"Front Neurosci"},{"key":"ref269","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.neuropharm.2015.11.006","article-title":"Purine nucleosides in neuroregeneration and neuroprotection","volume":"104","author":"Ribeiro","year":"2016","journal-title":"Neuropharmacology"},{"key":"ref270","doi-asserted-by":"publisher","first-page":"2376","DOI":"10.62347\/ZYVY9443","article-title":"Adenosine receptor subtype modulators: Insight into molecular mechanisms and their therapeutic application","volume":"17","author":"Solanki","year":"2025","journal-title":"Am J Transl Res"},{"key":"ref271","doi-asserted-by":"publisher","DOI":"10.3390\/cells9051075","article-title":"Adenosine A","volume":"9","author":"Franco","year":"2020","journal-title":"Cells"},{"key":"ref272","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2023.109503","article-title":"New paradigms in purinergic receptor ligand discovery","volume":"230","author":"Jacobson","year":"2023","journal-title":"Neuropharmacology"},{"key":"ref273","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27061890","article-title":"Therapeutic Potential of Highly Selective A","volume":"27","author":"Coppi","year":"2022","journal-title":"Molecules"},{"key":"ref274","doi-asserted-by":"publisher","first-page":"5041","DOI":"10.1111\/bph.17319","article-title":"Selective modulation of epileptic tissue by an adenosine A","volume":"181","author":"Ghosh","year":"2024","journal-title":"Br J Pharmacol"},{"key":"ref275","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.neuroscience.2006.09.010","article-title":"SRY-box containing gene 11 (Sox11) transcription factor is required for neuron survival and neurite growth","volume":"143","author":"Jankowski","year":"2006","journal-title":"Neuroscience"},{"key":"ref276","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/2952386","article-title":"The Extracellular Environment of the CNS: Influence on Plasticity, Sprouting, and Axonal Regeneration after Spinal Cord Injury","volume":"2018","author":"Quraishe","year":"2018","journal-title":"Neural Plast"},{"key":"ref277","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10102598","article-title":"Cell Reprogramming for Regeneration and Repair of the Nervous System","volume":"10","author":"Clark","year":"2022","journal-title":"Biomedicines"},{"key":"ref278","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1002\/dneu.22880","article-title":"In vivo glia-to-neuron conversion: pitfalls and solutions","volume":"82","author":"Wang","year":"2022","journal-title":"Dev Neurobiol"},{"key":"ref279","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1007\/s00702-017-1697-8","article-title":"Advances in optogenetic and chemogenetic methods to study brain circuits in non-human primates","volume":"125","author":"Galvan","year":"2018","journal-title":"J Neural Transm (Vienna)"},{"key":"ref280","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.pneurobio.2017.01.004","article-title":"Potential of GPCRs to modulate MAPK and mTOR pathways in Alzheimer\u2019s disease","volume":"149\u2013150","author":"Franco","year":"2017","journal-title":"Prog Neurobiol"},{"key":"ref281","doi-asserted-by":"publisher","DOI":"10.3389\/neuro.05.009.2010","article-title":"The histological slides and drawings of Cajal","volume":"4","author":"Garcia-Lopez","year":"2010","journal-title":"Front Neuroanat"},{"key":"ref282","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1038\/s41593-020-00783-4","article-title":"Reactive astrocyte nomenclature, definitions, and future directions","volume":"24","author":"Escartin","year":"2021","journal-title":"Nat Neurosci"},{"key":"ref283","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1136\/jnnp.74.9.1200","article-title":"Intrathecal inflammation precedes development of Alzheimer\u2019s disease","volume":"74","author":"Tarkowski","year":"2003","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref284","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-024-00740-w","article-title":"Astrocytic autophagy plasticity modulates A\u03b2 clearance and cognitive function in Alzheimer\u2019s disease","volume":"19","author":"Kim","year":"2024","journal-title":"Mol Neurodegener"},{"key":"ref285","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1016\/j.cmet.2022.05.011","article-title":"Astrocytic urea cycle detoxifies A\u03b2-derived ammonia while impairing memory in Alzheimer\u2019s disease","volume":"34","author":"Ju","year":"2022","journal-title":"Cell Metab"},{"key":"ref286","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1038\/nm.3639","article-title":"GABA from reactive astrocytes impairs memory in mouse models of Alzheimer\u2019s disease","volume":"20","author":"Jo","year":"2014","journal-title":"Nat Med"},{"key":"ref287","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1002\/glia.24110","article-title":"Inhibition of monoamine oxidase B prevents reactive astrogliosis and scar formation in stab wound injury model","volume":"70","author":"Chun","year":"2022","journal-title":"Glia"},{"key":"ref288","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.cub.2019.11.079","article-title":"Aberrant Tonic Inhibition of Dopaminergic Neuronal Activity Causes Motor Symptoms in Animal Models of Parkinson\u2019s Disease","volume":"30","author":"Heo","year":"2020","journal-title":"Curr Biol"},{"key":"ref289","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.107861","article-title":"Excessive Astrocytic GABA Causes Cortical Hypometabolism and Impedes Functional Recovery after Subcortical Stroke","volume":"32","author":"Nam","year":"2020","journal-title":"Cell Rep"},{"key":"ref290","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1007\/s13311-021-01097-4","article-title":"KDS2010, a Newly Developed Reversible MAO-B Inhibitor, as an Effective Therapeutic Candidate for Parkinson\u2019s Disease","volume":"18","author":"Nam","year":"2021","journal-title":"Neurotherapeutics"},{"key":"ref291","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/j.cell.2018.06.021","article-title":"Molecular Architecture of the Mouse Nervous System","volume":"174","author":"Zeisel","year":"2018","journal-title":"Cell"},{"key":"ref292","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2020.591690","article-title":"Astrocytes as Guardians of Neuronal Excitability: Mechanisms Underlying Epileptogenesis","volume":"11","author":"Verhoog","year":"2020","journal-title":"Front Neurol"},{"key":"ref293","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1002\/glia.440040215","article-title":"Astroglia in CNS injury","volume":"4","author":"Hatten","year":"1991","journal-title":"Glia"},{"key":"ref294","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1038\/nbt.1957","article-title":"Astrocytes from familial and sporadic ALS patients are toxic to motor neurons","volume":"29","author":"Haidet-Phillips","year":"2011","journal-title":"Nat Biotechnol"},{"key":"ref295","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1002\/glia.23250","article-title":"Astrocyte glycogen and lactate: New insights into learning and memory mechanisms","volume":"66","author":"Alberini","year":"2018","journal-title":"Glia"},{"key":"ref296","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.cmet.2011.08.016","article-title":"Brain energy metabolism: focus on astrocyte-neuron metabolic cooperation","volume":"14","author":"B\u00e9langer","year":"2011","journal-title":"Cell Metab"},{"key":"ref297","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-36209-5","article-title":"Astrocytic lactate dehydrogenase A regulates neuronal excitability and depressive-like behaviors through lactate homeostasis in mice","volume":"14","author":"Yao","year":"2023","journal-title":"Nat Commun"},{"key":"ref298","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2021.735532","article-title":"Lactate as an Astroglial Signal Augmenting Aerobic Glycolysis and Lipid Metabolism","volume":"12","author":"Horvat","year":"2021","journal-title":"Front Physiol"},{"key":"ref299","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1126\/science.1184334","article-title":"Channel-mediated tonic GABA release from glia","volume":"330","author":"Lee","year":"2010","journal-title":"Science"},{"key":"ref300","doi-asserted-by":"publisher","first-page":"4951","DOI":"10.1113\/jphysiol.2014.278754","article-title":"Glial GABA, synthesized by monoamine oxidase B, mediates tonic inhibition","volume":"592","author":"Yoon","year":"2014","journal-title":"J Physiol"},{"key":"ref301","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.neuron.2020.08.013","article-title":"Astrocytes Control Sensory Acuity via Tonic Inhibition in the Thalamus","volume":"108","author":"Kwak","year":"2020","journal-title":"Neuron"},{"key":"ref302","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/s41583-023-00724-7","article-title":"GABA tone regulation and its cognitive functions in the brain","volume":"24","author":"Koh","year":"2023","journal-title":"Nat Rev Neurosci"},{"key":"ref303","doi-asserted-by":"publisher","DOI":"10.1186\/1756-6606-5-38","article-title":"Protease activated receptor 1-induced glutamate release in cultured astrocytes is mediated by Bestrophin-1 channel but not by vesicular exocytosis","volume":"5","author":"Oh","year":"2012","journal-title":"Mol Brain"},{"key":"ref304","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1016\/j.neuron.2022.12.033","article-title":"Ventral tegmental area astrocytes modulate cocaine reward by tonically releasing GABA","volume":"111","author":"Yang","year":"2023","journal-title":"Neuron"},{"key":"ref305","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-024-00788-8","article-title":"SIRT2 and ALDH1A1 as critical enzymes for astrocytic GABA production in Alzheimer\u2019s disease","volume":"20","author":"Bhalla","year":"2025","journal-title":"Mol Neurodegener"},{"key":"ref306","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.biopsych.2021.10.012","article-title":"Astrocytes Render Memory Flexible by Releasing D-Serine and Regulating NMDA Receptor Tone in the Hippocampus","volume":"91","author":"Koh","year":"2022","journal-title":"Biol Psychiatry"},{"key":"ref307","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/nature04089","article-title":"Subunit arrangement and function in NMDA receptors","volume":"438","author":"Furukawa","year":"2005","journal-title":"Nature"},{"key":"ref308","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/s0896-6273(00)80086-0","article-title":"Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate","volume":"16","author":"Rothstein","year":"1996","journal-title":"Neuron"},{"key":"ref309","doi-asserted-by":"publisher","first-page":"3929","DOI":"10.1113\/jphysiol.2011.207340","article-title":"State-dependent changes in astrocyte regulation of extrasynaptic NMDA receptor signalling in neurosecretory neurons","volume":"589","author":"Fleming","year":"2011","journal-title":"J Physiol"},{"key":"ref310","doi-asserted-by":"publisher","DOI":"10.3389\/fnsyn.2019.00010","article-title":"Control of Long-Term Plasticity by Glutamate Transporters","volume":"11","author":"Valtcheva","year":"2019","journal-title":"Front Synaptic Neurosci"},{"key":"ref311","doi-asserted-by":"publisher","first-page":"120","DOI":"10.5607\/en.2018.27.2.120","article-title":"Expression of \u00b5-Opioid Receptor in CA1 Hippocampal Astrocytes","volume":"27","author":"Nam","year":"2018","journal-title":"Exp Neurobiol"},{"key":"ref312","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1007\/s11064-019-02888-0","article-title":"Astrocytic Metabolism Focusing on Glutamate Homeostasis: A Short Review Dedicated to Vittorio Gallo","volume":"45","author":"Schousboe","year":"2020","journal-title":"Neurochem Res"},{"key":"ref313","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1042\/BST20130237","article-title":"Astrocyte glutamine synthetase: pivotal in health and disease","volume":"41","author":"Rose","year":"2013","journal-title":"Biochem Soc Trans"},{"key":"ref314","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1038\/sj.jcbfm.9600257","article-title":"A metabolomic approach to ionotropic glutamate receptor subtype function: a nuclear magnetic resonance in vitro investigation","volume":"26","author":"Rae","year":"2006","journal-title":"J Cereb Blood Flow Metab"},{"key":"ref315","doi-asserted-by":"publisher","DOI":"10.3390\/biom13050819","article-title":"ASC Transporters Mediate D-Serine Transport into Astrocytes Adjacent to Synapses in the Mouse Brain","volume":"13","author":"Krishnan","year":"2023","journal-title":"Biomolecules"},{"key":"ref316","doi-asserted-by":"publisher","first-page":"5606","DOI":"10.1073\/pnas.0408483102","article-title":"Glutamate receptor activation triggers a calcium-dependent and SNARE protein-dependent release of the gliotransmitter D-serine","volume":"102","author":"Mothet","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref317","doi-asserted-by":"publisher","first-page":"10143","DOI":"10.1523\/JNEUROSCI.5779-12.2013","article-title":"TRPA1 channels are regulators of astrocyte basal calcium levels and long-term potentiation via constitutive D-serine release","volume":"33","author":"Shigetomi","year":"2013","journal-title":"J Neurosci"},{"key":"ref318","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/nature08673","article-title":"Long-term potentiation depends on release of D-serine from astrocytes","volume":"463","author":"Henneberger","year":"2010","journal-title":"Nature"},{"key":"ref319","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1093\/cercor\/bhr254","article-title":"Immunogold detection of L-glutamate and D-serine in small synaptic-like microvesicles in adult hippocampal astrocytes","volume":"22","author":"Bergersen","year":"2012","journal-title":"Cereb Cortex"},{"key":"ref320","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2021.754032","article-title":"An Overview of the Involvement of D-Serine in Cognitive Impairment in Normal Aging and Dementia","volume":"12","author":"Orzylowski","year":"2021","journal-title":"Front Psychiatry"},{"key":"ref321","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/j.tins.2021.07.004","article-title":"Astrocyte and neuron cooperation in long-term depression","volume":"44","author":"Durkee","year":"2021","journal-title":"Trends Neurosci"},{"key":"ref322","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms13772","article-title":"Glia-derived ATP inversely regulates excitability of pyramidal and CCK-positive neurons","volume":"8","author":"Tan","year":"2017","journal-title":"Nat Commun"},{"key":"ref323","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2020.105363","article-title":"Of adenosine and the blues: The adenosinergic system in the pathophysiology and treatment of major depressive disorder","volume":"163","author":"Gomes","year":"2021","journal-title":"Pharmacol Res"},{"key":"ref324","doi-asserted-by":"publisher","first-page":"17","DOI":"10.5607\/en.2015.24.1.17","article-title":"Ca(2+) Entry is Required for Mechanical Stimulation-induced ATP Release from Astrocyte","volume":"24","author":"Lee","year":"2015","journal-title":"Exp Neurobiol"},{"key":"ref325","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2018.00224","article-title":"Ca","volume":"11","author":"Xiong","year":"2018","journal-title":"Front Mol Neurosci"},{"key":"ref326","doi-asserted-by":"publisher","DOI":"10.1016\/j.conb.2023.102685","article-title":"How astrocytic ATP shapes neuronal activity and brain circuits","volume":"79","author":"Lezmy","year":"2023","journal-title":"Curr Opin Neurobiol"},{"key":"ref327","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1046\/j.1471-4159.2001.00607.x","article-title":"Adenosine in the central nervous system: release mechanisms and extracellular concentrations","volume":"79","author":"Latini","year":"2001","journal-title":"J Neurochem"},{"key":"ref328","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1097\/00001756-199505300-00006","article-title":"Mendon\u00e7a Ad, Sebasti\u00e3o AM, Ribeiro JA. Inhibition of NMDA receptor-mediated currents in isolated rat hippocampal neurones by adenosine A1 receptor activation","volume":"6","year":"1995","journal-title":"Neuroreport"},{"key":"ref329","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1016\/s0028-3908(99)00237-3","article-title":"Purinergic modulation of [(3)H]GABA release from rat hippocampal nerve terminals","volume":"39","author":"Cunha","year":"2000","journal-title":"Neuropharmacology"},{"key":"ref330","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-06731-y","article-title":"Astrocytes detect and upregulate transmission at inhibitory synapses of somatostatin interneurons onto pyramidal cells","volume":"9","author":"Matos","year":"2018","journal-title":"Nat Commun"},{"key":"ref331","doi-asserted-by":"publisher","first-page":"2282","DOI":"10.1093\/cercor\/bhu035","article-title":"ATP-P2X7 Receptor Modulates Axon Initial Segment Composition and Function in Physiological Conditions and Brain Injury","volume":"25","author":"Puerto","year":"2015","journal-title":"Cereb Cortex"},{"key":"ref332","doi-asserted-by":"publisher","first-page":"E2832","DOI":"10.1073\/pnas.1206557109","article-title":"Nucleus basalis-enabled stimulus-specific plasticity in the visual cortex is mediated by astrocytes","volume":"109","author":"Chen","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref333","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.32237","article-title":"Neuronal activity determines distinct gliotransmitter release from a single astrocyte","volume":"7","author":"Covelo","year":"2018","journal-title":"Elife"},{"key":"ref334","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1126\/science.1116916","article-title":"Astrocytic purinergic signaling coordinates synaptic networks","volume":"310","author":"Pascual","year":"2005","journal-title":"Science"},{"key":"ref335","doi-asserted-by":"publisher","first-page":"3266","DOI":"10.1093\/cercor\/bhy194","article-title":"Adenosine Receptor-Mediated Developmental Loss of Spike Timing-Dependent Depression in the Hippocampus","volume":"29","author":"P\u00e9rez-Rodr\u00edguez","year":"2019","journal-title":"Cereb Cortex"},{"key":"ref336","doi-asserted-by":"publisher","first-page":"5370","DOI":"10.1523\/JNEUROSCI.5255-05.2006","article-title":"GABAergic network activation of glial cells underlies hippocampal heterosynaptic depression","volume":"26","author":"Serrano","year":"2006","journal-title":"J Neurosci"},{"key":"ref337","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/s0896-6273(03)00717-7","article-title":"ATP released by astrocytes mediates glutamatergic activity-dependent heterosynaptic suppression","volume":"40","author":"Zhang","year":"2003","journal-title":"Neuron"},{"key":"ref338","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.neuron.2008.11.024","article-title":"Astrocytic modulation of sleep homeostasis and cognitive consequences of sleep loss","volume":"61","author":"Halassa","year":"2009","journal-title":"Neuron"},{"key":"ref339","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1113\/jphysiol.2002.028423","article-title":"Long-lasting modulation of synaptic input to Purkinje neurons by Bergmann glia stimulation in rat brain slices","volume":"545","author":"Brockhaus","year":"2002","journal-title":"J Physiol"},{"key":"ref340","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1523\/JNEUROSCI.21-07-02215.2001","article-title":"Propagation of intercellular calcium waves in retinal astrocytes and M\u00fcller cells","volume":"21","author":"Newman","year":"2001","journal-title":"J Neurosci"},{"key":"ref341","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1038\/nn.4649","article-title":"Synapse-specific astrocyte gating of amygdala-related behavior","volume":"20","author":"Martin-Fernandez","year":"2017","journal-title":"Nat Neurosci"},{"key":"ref342","doi-asserted-by":"publisher","DOI":"10.3390\/cells8060586","article-title":"Opioid-Mediated Astrocyte-Neuron Signaling in the Nucleus Accumbens","volume":"8","author":"Corkrum","year":"2019","journal-title":"Cells"},{"key":"ref343","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.cell.2011.07.022","article-title":"Astrocytes are endogenous regulators of basal transmission at central synapses","volume":"146","author":"Panatier","year":"2011","journal-title":"Cell"},{"key":"ref344","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1002\/hipo.22392","article-title":"Synaptic mechanisms of adenosine A2A receptor-mediated hyperexcitability in the hippocampus","volume":"25","author":"Rombo","year":"2015","journal-title":"Hippocampus"},{"key":"ref345","doi-asserted-by":"publisher","DOI":"10.1038\/S41467-023-37601-X","article-title":"Lateral septum adenosine A2A receptors control stress-induced depressive-like behaviors via signaling to the hypothalamus and habenula","volume":"14","author":"Wang","year":"2023","journal-title":"Nat Commun"},{"key":"ref346","doi-asserted-by":"publisher","first-page":"155","DOI":"10.5607\/en.2018.27.3.155","article-title":"Astrocytic proBDNF and Tonic GABA Distinguish Active versus Reactive Astrocytes in Hippocampus","volume":"27","author":"Chun","year":"2018","journal-title":"Exp Neurobiol"},{"key":"ref347","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/j.neuron.2016.09.031","article-title":"Peri-Synaptic Glia Recycles Brain-Derived Neurotrophic Factor for LTP Stabilization and Memory Retention","volume":"92","author":"Vignoli","year":"2016","journal-title":"Neuron"},{"key":"ref348","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.neures.2017.11.012","article-title":"Reactive astrocytes in Alzheimer\u2019s disease: A double-edged sword","volume":"126","author":"Chun","year":"2018","journal-title":"Neurosci Res"},{"key":"ref349","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.neures.2023.02.001","article-title":"Astrocytes and brain-derived neurotrophic factor (BDNF)","volume":"197","author":"Albini","year":"2023","journal-title":"Neurosci Res"},{"key":"ref350","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-00693-w","article-title":"Endocytic BDNF secretion regulated by Vamp3 in astrocytes","volume":"11","author":"Han","year":"2021","journal-title":"Sci Rep"},{"key":"ref351","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/nature01983","article-title":"Truncated TrkB-T1 mediates neurotrophin-evoked calcium signalling in glia cells","volume":"426","author":"Rose","year":"2003","journal-title":"Nature"},{"key":"ref352","doi-asserted-by":"publisher","first-page":"40464","DOI":"10.1074\/jbc.M111.232009","article-title":"Brain-derived neurotrophic factor (BDNF) enhances GABA transport by modulating the trafficking of GABA transporter-1 (GAT-1) from the plasma membrane of rat cortical astrocytes","volume":"286","author":"Vaz","year":"2011","journal-title":"J Biol Chem"},{"key":"ref353","doi-asserted-by":"publisher","first-page":"5803","DOI":"10.1242\/jcs.01511","article-title":"Truncated TrkB receptor-induced outgrowth of dendritic filopodia involves the p75 neurotrophin receptor","volume":"117","author":"Hartmann","year":"2004","journal-title":"J Cell Sci"},{"key":"ref354","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1111\/j.1460-9568.2007.05282.x","article-title":"Truncated TrkB-T1 regulates the morphology of neocortical layer I astrocytes in adult rat brain slices","volume":"25","author":"Ohira","year":"2007","journal-title":"Eur J Neurosci"},{"key":"ref355","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1523\/JNEUROSCI.4436-04.2005","article-title":"A truncated tropomyosin-related kinase B receptor, T1, regulates glial cell morphology via Rho GDP dissociation inhibitor 1","volume":"25","author":"Ohira","year":"2005","journal-title":"J Neurosci"},{"key":"ref356","doi-asserted-by":"publisher","first-page":"2618","DOI":"10.1016\/j.pain.2014.09.027","article-title":"TRAF6 upregulation in spinal astrocytes maintains neuropathic pain by integrating TNF-\u03b1 and IL-1\u03b2 signaling","volume":"155","author":"Lu","year":"2014","journal-title":"Pain"},{"key":"ref357","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.it.2020.07.007","article-title":"The Role of Astrocytes in CNS Inflammation","volume":"41","author":"Giovannoni","year":"2020","journal-title":"Trends Immunol"},{"key":"ref358","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/j.neuron.2020.08.012","article-title":"Astrocyte Crosstalk in CNS Inflammation","volume":"108","author":"Linnerbauer","year":"2020","journal-title":"Neuron"},{"key":"ref359","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.12781","article-title":"The role of astrocytes in oxidative stress of central nervous system: A mixed blessing","volume":"53","author":"Chen","year":"2020","journal-title":"Cell Prolif"},{"key":"ref360","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1038\/s41593-020-00735-y","article-title":"Severe reactive astrocytes precipitate pathological hallmarks of Alzheimer\u2019s disease via H","volume":"23","author":"Chun","year":"2020","journal-title":"Nat Neurosci"},{"key":"ref361","unstructured":"Hemoglobin as a peroxidase and drug target for oxidative stress-related diseases. BioRxiv 594979 [Preprint]. 2024 [cited 2025 Dec 10]. Available from: https:\/\/www.biorxiv.org\/content\/10.1101\/2024.05.21.594979v2"},{"key":"ref362","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1016\/j.bbadis.2007.03.006","article-title":"Transient receptor potential channels in Alzheimer\u2019s disease","volume":"1772","author":"Yamamoto","year":"2007","journal-title":"Biochim Biophys Acta"},{"key":"ref363","doi-asserted-by":"publisher","DOI":"10.3390\/antiox10050739","article-title":"The Role of NADPH Oxidase in Neuronal Death and Neurogenesis after Acute Neurological Disorders","volume":"10","author":"Lee","year":"2021","journal-title":"Antioxidants (Basel)"},{"key":"ref364","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1515\/BC.2003.152","article-title":"Regulation of the expression of inducible nitric oxide synthase","volume":"384","author":"Kleinert","year":"2003","journal-title":"Biol Chem"},{"key":"ref365","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1097\/NEN.0b013e3181cb5af4","article-title":"Oxidative stress in the progression of Alzheimer disease in the frontal cortex","volume":"69","author":"Ansari","year":"2010","journal-title":"J Neuropathol Exp Neurol"},{"key":"ref366","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2017.00412","article-title":"The Oxidative Stress-Induced Increase in the Membrane Expression of the Water-Permeable Channel Aquaporin-4 in Astrocytes Is Regulated by Caveolin-1 Phosphorylation","volume":"11","author":"Bi","year":"2017","journal-title":"Front Cell Neurosci"},{"key":"ref367","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.mam.2004.02.011","article-title":"Enriched environment, nitric oxide production and synaptic plasticity prevent the aging-dependent impairment of spatial cognition","volume":"25","author":"Arnaiz","year":"2004","journal-title":"Mol Aspects Med"},{"key":"ref368","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-04831-8","article-title":"NOX activation in reactive astrocytes regulates astrocytic LCN2 expression and neurodegeneration","volume":"13","author":"Liu","year":"2022","journal-title":"Cell Death Dis"},{"key":"ref369","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/s0301-0082(00)00067-8","article-title":"Glutamate uptake","volume":"65","author":"Danbolt","year":"2001","journal-title":"Prog Neurobiol"},{"key":"ref370","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2020.00090","article-title":"Going the Extra (Synaptic) Mile: Excitotoxicity as the Road Toward Neurodegenerative Diseases","volume":"14","author":"Armada-Moreira","year":"2020","journal-title":"Front Cell Neurosci"},{"key":"ref371","doi-asserted-by":"publisher","first-page":"9736","DOI":"10.1523\/JNEUROSCI.3009-07.2007","article-title":"Extracellular glutamate concentration in hippocampal slice","volume":"27","author":"Herman","year":"2007","journal-title":"J Neurosci"},{"key":"ref372","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2019.00357","article-title":"Glutamate Transporters in Hippocampal LTD\/LTP: Not Just Prevention of Excitotoxicity","volume":"13","author":"Gon\u00e7alves-Ribeiro","year":"2019","journal-title":"Front Cell Neurosci"},{"key":"ref373","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.neuint.2016.05.009","article-title":"Neuronal vs glial glutamate uptake: Resolving the conundrum","volume":"98","author":"Danbolt","year":"2016","journal-title":"Neurochem Int"},{"key":"ref374","doi-asserted-by":"publisher","first-page":"97","DOI":"10.3233\/jad-2007-11113","article-title":"Alterations in expression of glutamatergic transporters and receptors in sporadic Alzheimer\u2019s disease","volume":"11","author":"Jacob","year":"2007","journal-title":"J Alzheimers Dis"},{"key":"ref375","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.neuint.2004.03.007","article-title":"Glutamate-mediated excitotoxicity and neurodegeneration in Alzheimer\u2019s disease","volume":"45","author":"Hynd","year":"2004","journal-title":"Neurochem Int"},{"key":"ref376","doi-asserted-by":"publisher","first-page":"E2518","DOI":"10.1073\/pnas.1306832110","article-title":"A\u03b2 induces astrocytic glutamate release, extrasynaptic NMDA receptor activation, and synaptic loss","volume":"110","author":"Talantova","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref377","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1073\/pnas.032539299","article-title":"Focal loss of the glutamate transporter EAAT2 in a transgenic rat model of SOD1 mutant-mediated amyotrophic lateral sclerosis (ALS)","volume":"99","author":"Howland","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref378","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.expneurol.2006.03.028","article-title":"Loss of the astrocyte glutamate transporter GLT1 modifies disease in SOD1(G93A) mice","volume":"201","author":"Pardo","year":"2006","journal-title":"Exp Neurol"},{"key":"ref379","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1523\/JNEUROSCI.23-05-01688.2003","article-title":"Impaired spinal cord glutamate transport capacity and reduced sensitivity to riluzole in a transgenic superoxide dismutase mutant rat model of amyotrophic lateral sclerosis","volume":"23","author":"Dunlop","year":"2003","journal-title":"J Neurosci"},{"key":"ref380","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2024.106435","article-title":"Communication defects with astroglia contribute to early impairments in the motor cortex plasticity of SOD1","volume":"193","author":"Costa-Pinto","year":"2024","journal-title":"Neurobiol Dis"},{"key":"ref381","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/s0896-6273(00)80997-6","article-title":"Aberrant RNA processing in a neurodegenerative disease: the cause for absent EAAT2, a glutamate transporter, in amyotrophic lateral sclerosis","volume":"20","author":"Lin","year":"1998","journal-title":"Neuron"},{"key":"ref382","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1002\/ana.20003","article-title":"Altered expression of the glutamate transporter EAAT2b in neurological disease","volume":"55","author":"Maragakis","year":"2004","journal-title":"Ann Neurol"},{"key":"ref383","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1002\/glia.20673","article-title":"Differential involvement of TNF alpha in hypoxic suppression of astrocyte glutamate transporters","volume":"56","author":"Boycott","year":"2008","journal-title":"Glia"},{"key":"ref384","doi-asserted-by":"publisher","first-page":"3103","DOI":"10.1172\/JCI127695","article-title":"Membralin deficiency dysregulates astrocytic glutamate homeostasis leading to ALS-like impairment","volume":"129","author":"Jiang","year":"2019","journal-title":"J Clin Invest"},{"key":"ref385","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.pharmthera.2007.01.010","article-title":"Astrocyte elevated gene-1: recent insights into a novel gene involved in tumor progression, metastasis and neurodegeneration","volume":"114","author":"Emdad","year":"2007","journal-title":"Pharmacol Ther"},{"key":"ref386","doi-asserted-by":"publisher","first-page":"32480","DOI":"10.1074\/jbc.M704314200","article-title":"A caspase-3-cleaved fragment of the glial glutamate transporter EAAT2 is sumoylated and targeted to promyelocytic leukemia nuclear bodies in mutant SOD1-linked amyotrophic lateral sclerosis","volume":"282","author":"Gibb","year":"2007","journal-title":"J Biol Chem"},{"key":"ref387","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.expneurol.2017.03.014","article-title":"Mutation of the caspase-3 cleavage site in the astroglial glutamate transporter EAAT2 delays disease progression and extends lifespan in the SOD1-G93A mouse model of ALS","volume":"292","author":"Rosenblum","year":"2017","journal-title":"Exp Neurol"},{"key":"ref388","doi-asserted-by":"publisher","first-page":"5574","DOI":"10.1523\/JNEUROSCI.3582-16.2017","article-title":"MicroRNA Profiling Reveals Marker of Motor Neuron Disease in ALS Models","volume":"37","author":"Hoye","year":"2017","journal-title":"J Neurosci"},{"key":"ref389","doi-asserted-by":"publisher","first-page":"2561","DOI":"10.1093\/brain\/awy182","article-title":"Motor neuron-derived microRNAs cause astrocyte dysfunction in amyotrophic lateral sclerosis","volume":"141","author":"Hoye","year":"2018","journal-title":"Brain"},{"key":"ref390","doi-asserted-by":"publisher","first-page":"7105","DOI":"10.1074\/jbc.M112.410944","article-title":"Neuronal exosomal miRNA-dependent translational regulation of astroglial glutamate transporter GLT1","volume":"288","author":"Morel","year":"2013","journal-title":"J Biol Chem"},{"key":"ref391","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/j.bbrc.2018.02.132","article-title":"Spinal cord-specific deletion of the glutamate transporter GLT1 causes motor neuron death in mice","volume":"497","author":"Sugiyama","year":"2018","journal-title":"Biochem Biophys Res Commun"},{"key":"ref392","doi-asserted-by":"publisher","first-page":"2519","DOI":"10.1093\/hmg\/ddg267","article-title":"Increased expression of the glial glutamate transporter EAAT2 modulates excitotoxicity and delays the onset but not the outcome of ALS in mice","volume":"12","author":"Guo","year":"2003","journal-title":"Hum Mol Genet"},{"key":"ref393","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/nature03180","article-title":"Beta-lactam antibiotics offer neuroprotection by increasing glutamate transporter expression","volume":"433","author":"Rothstein","year":"2005","journal-title":"Nature"},{"key":"ref394","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1016\/S1474-4422(14)70222-4","article-title":"Safety and efficacy of ceftriaxone for amyotrophic lateral sclerosis: a multi-stage, randomised, double-blind, placebo-controlled trial","volume":"13","author":"Cudkowicz","year":"2014","journal-title":"Lancet Neurol"},{"key":"ref395","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1002\/ana.10561","article-title":"Of mice and men: reconciling preclinical ALS mouse studies and human clinical trials","volume":"53","author":"Rothstein","year":"2003","journal-title":"Ann Neurol"},{"key":"ref396","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1080\/14660820510012040","article-title":"New ideas for therapy in ALS: critical considerations","volume":"7","author":"Beghi","year":"2006","journal-title":"Amyotroph Lateral Scler"},{"key":"ref397","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1002\/jnr.10825","article-title":"Glutamate uptake inhibitor L-trans-pyrrolidine 2,4-dicarboxylate becomes neurotoxic in the presence of subthreshold concentrations of mitochondrial toxin 3-nitropropionate: involvement of mitochondrial reducing activity and ATP production","volume":"74","author":"Garc\u00eda","year":"2003","journal-title":"J Neurosci Res"},{"key":"ref398","doi-asserted-by":"publisher","DOI":"10.3390\/metabo12070574","article-title":"Metabolic Dysfunction in Motor Neuron Disease: Shedding Light through the Lens of Autophagy","volume":"12","author":"Silva","year":"2022","journal-title":"Metabolites"},{"key":"ref399","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1002\/jnr.21108","article-title":"Inhibitors of glutamate transport modulate distinct patterns in brain metabolism","volume":"85","author":"Moussa","year":"2007","journal-title":"J Neurosci Res"},{"key":"ref400","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1177\/1087057110370998","article-title":"Identification of translational activators of glial glutamate transporter EAAT2 through cell-based high-throughput screening: an approach to prevent excitotoxicity","volume":"15","author":"Colton","year":"2010","journal-title":"J Biomol Screen"},{"key":"ref401","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1172\/JCI66163","article-title":"Small-molecule activator of glutamate transporter EAAT2 translation provides neuroprotection","volume":"124","author":"Kong","year":"2014","journal-title":"J Clin Invest"},{"key":"ref402","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2021.661412","article-title":"The Effect of GLT-1 Upregulation on Extracellular Glutamate Dynamics","volume":"15","author":"Wilkie","year":"2021","journal-title":"Front Cell Neurosci"},{"key":"ref403","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1007\/s12031-015-0695-2","article-title":"Multifactorial Gene Therapy Enhancing the Glutamate Uptake System and Reducing Oxidative Stress Delays Symptom Onset and Prolongs Survival in the SOD1-G93A ALS Mouse Model","volume":"58","author":"Benkler","year":"2016","journal-title":"J Mol Neurosci"},{"key":"ref404","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1002\/glia.22878","article-title":"Mechanisms underlying AQP4 accumulation in astrocyte endfeet","volume":"63","author":"Camassa","year":"2015","journal-title":"Glia"},{"key":"ref405","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3003748","article-title":"A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid \u03b2","volume":"4","author":"Iliff","year":"2012","journal-title":"Sci Transl Med"},{"key":"ref406","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-015-0056-1","article-title":"Deletion of aquaporin-4 in APP\/PS1 mice exacerbates brain A\u03b2 accumulation and memory deficits","volume":"10","author":"Xu","year":"2015","journal-title":"Mol Neurodegener"},{"key":"ref407","doi-asserted-by":"publisher","first-page":"711","DOI":"10.3233\/JAD-2011-110725","article-title":"Loss of astrocyte polarization in the tg-ArcSwe mouse model of Alzheimer\u2019s disease","volume":"27","author":"Yang","year":"2011","journal-title":"J Alzheimers Dis"},{"key":"ref408","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1002\/ana.24271","article-title":"Impairment of paravascular clearance pathways in the aging brain","volume":"76","author":"Kress","year":"2014","journal-title":"Ann Neurol"},{"key":"ref409","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1097\/NEN.0b013e3181fd252c","article-title":"Aquaporin expression in the brains of patients with or without cerebral amyloid angiopathy","volume":"69","author":"Moftakhar","year":"2010","journal-title":"J Neuropathol Exp Neurol"},{"key":"ref410","doi-asserted-by":"publisher","first-page":"2576","DOI":"10.1093\/brain\/awaa179","article-title":"Impaired glymphatic function and clearance of tau in an Alzheimer's disease model","volume":"143","author":"Harrison","year":"2020","journal-title":"Brain"},{"key":"ref411","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.neuroscience.2012.06.002","article-title":"Hippocampal tissue of patients with refractory temporal lobe epilepsy is associated with astrocyte activation, inflammation, and altered expression of channels and receptors","volume":"220","author":"Das","year":"2012","journal-title":"Neuroscience"},{"key":"ref412","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1016\/j.cell.2015.10.067","article-title":"Establishment and Dysfunction of the Blood-Brain Barrier","volume":"163","author":"Zhao","year":"2015","journal-title":"Cell"},{"key":"ref413","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-022-01498-2","article-title":"Sleep fragmentation affects glymphatic system through the different expression of AQP4 in wild type and 5xFAD mouse models","volume":"11","author":"Vasciaveo","year":"2023","journal-title":"Acta Neuropathol Commun"},{"key":"ref414","doi-asserted-by":"publisher","DOI":"10.1186\/s42466-021-00102-7","article-title":"Glymphatic system, AQP4, and their implications in Alzheimer\u2019s disease","volume":"3","author":"Silva","year":"2021","journal-title":"Neurol Res Pract"},{"key":"ref415","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1084\/jem.20050304","article-title":"IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel","volume":"202","author":"Lennon","year":"2005","journal-title":"J Exp Med"},{"key":"ref416","doi-asserted-by":"publisher","first-page":"30578","DOI":"10.1074\/jbc.M114.582221","article-title":"Identification of a point mutation impairing the binding between aquaporin-4 and neuromyelitis optica autoantibodies","volume":"289","author":"Pisani","year":"2014","journal-title":"J Biol Chem"},{"key":"ref417","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1016\/j.neuroscience.2009.11.062","article-title":"Functional and molecular interactions between aquaporins and Na,K-ATPase","volume":"168","author":"Illarionova","year":"2010","journal-title":"Neuroscience"},{"key":"ref418","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-023-02614-z","article-title":"Melatonin alleviates depression-like behaviors and cognitive dysfunction in mice by regulating the circadian rhythm of AQP4 polarization","volume":"13","author":"Yao","year":"2023","journal-title":"Transl Psychiatry"},{"key":"ref419","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2019.107827","article-title":"Affinity-matured \u2018aquaporumab\u2019 anti-aquaporin-4 antibody for therapy of seropositive neuromyelitis optica spectrum disorders","volume":"162","author":"Duan","year":"2020","journal-title":"Neuropharmacology"},{"key":"ref420","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1177\/0271678X241264407","article-title":"Preliminary investigations into human neurofluid transport using multiple novel non-contrast MRI methods","volume":"44","author":"Rane","year":"2024","journal-title":"J Cereb Blood Flow Metab"},{"key":"ref421","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21175996","article-title":"P2X7 Receptors Amplify CNS Damage in Neurodegenerative Diseases","volume":"21","author":"Illes","year":"2020","journal-title":"Int J Mol Sci"},{"key":"ref422","doi-asserted-by":"publisher","first-page":"4843","DOI":"10.1073\/pnas.0735876100","article-title":"Translational control of inducible nitric oxide synthase expression by arginine can explain the arginine paradox","volume":"100","author":"Lee","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref423","doi-asserted-by":"publisher","DOI":"10.1111\/jnc.16299","article-title":"Impact of Glucocorticoid-Associated Stress-Like Conditions on Aquaporin-4 in Cultured Astrocytes and Its Modulation by Adenosine A","volume":"169","author":"Dias","year":"2025","journal-title":"J Neurochem"},{"key":"ref424","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1002\/glia.23747","article-title":"Role of astrocyte purinergic signaling in epilepsy","volume":"68","author":"Nikolic","year":"2020","journal-title":"Glia"},{"key":"ref425","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1002\/glia.22817","article-title":"Enhanced astroglial Ca","volume":"63","author":"\u00c1lvarez-Ferradas","year":"2015","journal-title":"Glia"},{"key":"ref426","doi-asserted-by":"publisher","first-page":"2673","DOI":"10.1002\/glia.23519","article-title":"Blocking TNF\u03b1-driven astrocyte purinergic signaling restores normal synaptic activity during epileptogenesis","volume":"66","author":"Nikolic","year":"2018","journal-title":"Glia"},{"key":"ref427","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01529","article-title":"Modulation of P2X7 Receptor during Inflammation in Multiple Sclerosis","volume":"8","author":"Amadio","year":"2017","journal-title":"Front Immunol"},{"key":"ref428","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s11302-007-9069-8","article-title":"Mapping P2X and P2Y receptor proteins in striatum and substantia nigra: An immunohistological study","volume":"3","author":"Amadio","year":"2007","journal-title":"Purinergic Signal"},{"key":"ref429","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1002\/jnr.24699","article-title":"Central nervous system-infiltrated immune cells induce calcium increase in astrocytes via astroglial purinergic signaling","volume":"98","author":"Bijeli\u0107","year":"2020","journal-title":"J Neurosci Res"},{"key":"ref430","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mcn.2016.02.003","article-title":"Early P2X7R-related astrogliosis in autoimmune encephalomyelitis","volume":"74","author":"Grygorowicz","year":"2016","journal-title":"Mol Cell Neurosci"},{"key":"ref431","doi-asserted-by":"publisher","first-page":"133","DOI":"10.2169\/internalmedicine.38.133","article-title":"Adenosine and neopterin levels in cerebrospinal fluid of patients with neurological disorders","volume":"38","author":"Yoshida","year":"1999","journal-title":"Intern Med"},{"key":"ref432","doi-asserted-by":"publisher","first-page":"406","DOI":"10.3109\/21678421.2013.793358","article-title":"A2A adenosine receptors are up-regulated in lymphocytes from amyotrophic lateral sclerosis patients","volume":"14","author":"Vincenzi","year":"2013","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"ref433","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0272104","article-title":"Changes in adenosine receptors and neurotrophic factors in the SOD1G93A mouse model of amyotrophic lateral sclerosis: Modulation by chronic caffeine","volume":"17","author":"Rei","year":"2022","journal-title":"PLoS One"},{"key":"ref434","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2020.108106","article-title":"Hippocampal synaptic dysfunction in the SOD1","volume":"171","author":"Rei","year":"2020","journal-title":"Neuropharmacology"},{"key":"ref435","doi-asserted-by":"publisher","unstructured":"Vaz SH, Pinto S, Sebasti\u00e3o AM, Brites D. Astrocytes in Amyotrophic Lateral Sclerosis","DOI":"10.36255\/exonpublications.amyotrophiclateralsclerosis.astrocytes.2021"},{"key":"ref436","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1016\/S1474-4422(18)30318-1","article-title":"The glymphatic pathway in neurological disorders","volume":"17","author":"Rasmussen","year":"2018","journal-title":"Lancet Neurol"},{"key":"ref437","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22147491","article-title":"The Glymphatic System (En)during Inflammation","volume":"22","author":"Mogensen","year":"2021","journal-title":"Int J Mol Sci"},{"key":"ref438","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/2410264","article-title":"Adenosine Receptor A1-A2a Heteromers Regulate EAAT2 Expression and Glutamate Uptake via YY1-Induced Repression of PPAR","volume":"2020","author":"Hou","year":"2020","journal-title":"PPAR Res"},{"key":"ref439","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1002\/glia.23046","article-title":"The \u201cBig-Bang\u201d for modern glial biology: Translation and comments on P\u00edo del R\u00edo-Hortega 1919 series of papers on microglia","volume":"64","author":"Sierra","year":"2016","journal-title":"Glia"},{"key":"ref440","first-page":"440","article-title":"Studies on neuroglia: Glia with very few processes (oligodendroglia) by P\u00c3-o del R\u00c3-o-Hortega. 1921","volume":"31","author":"Del","year":"2012","journal-title":"Clin Neuropathol"},{"key":"ref441","doi-asserted-by":"publisher","DOI":"10.1177\/1759091420953259","article-title":"History of Neuroscience I. P\u00edo del R\u00edo-Hortega (1882-1945): The Discoverer of Microglia and Oligodendroglia","volume":"12","author":"Boullerne","year":"2020","journal-title":"ASN Neuro"},{"key":"ref442","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1080\/00207454.2016.1212854","article-title":"Neuroinflammation pathways: a general review","volume":"127","author":"Shabab","year":"2017","journal-title":"Int J Neurosci"},{"key":"ref443","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3233\/JAD-230273","article-title":"Microglial TLR4\/NLRP3 Inflammasome Signaling in Alzheimer\u2019s Disease","volume":"97","author":"Li","year":"2024","journal-title":"J Alzheimers Dis"},{"key":"ref444","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2020.602508","article-title":"TLR4 Targeting as a Promising Therapeutic Strategy for Alzheimer Disease Treatment","volume":"14","author":"Zhou","year":"2020","journal-title":"Front Neurosci"},{"key":"ref445","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1111\/jnc.14687","article-title":"Nuclear factor-kappa \u03b2 as a therapeutic target for Alzheimer\u2019s disease","volume":"150","author":"Jha","year":"2019","journal-title":"J Neurochem"},{"key":"ref446","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-25767-1","article-title":"Selective targeting of the TLR2\/MyD88\/NF-\u03baB pathway reduces \u03b1-synuclein spreading in vitro and in vivo","volume":"12","author":"Dutta","year":"2021","journal-title":"Nat Commun"},{"key":"ref447","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/s41591-019-0695-9","article-title":"Human and mouse single-nucleus transcriptomics reveal TREM2-dependent and TREM2-independent cellular responses in Alzheimer's disease","volume":"26","author":"Zhou","year":"2020","journal-title":"Nat Med"},{"key":"ref448","doi-asserted-by":"publisher","DOI":"10.1016\/j.mad.2021.111438","article-title":"TREM2, microglia, and Alzheimer\u2019s disease","volume":"195","author":"Qin","year":"2021","journal-title":"Mech Ageing Dev"},{"key":"ref449","doi-asserted-by":"publisher","first-page":"4153","DOI":"10.1016\/j.cell.2022.09.033","article-title":"TREM2 drives microglia response to amyloid-\u03b2 via SYK-dependent and -independent pathways","volume":"185","author":"Wang","year":"2022","journal-title":"Cell"},{"key":"ref450","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/j.neuron.2018.01.031","article-title":"TREM2 Is a Receptor for \u03b2-Amyloid that Mediates Microglial Function","volume":"97","author":"Zhao","year":"2018","journal-title":"Neuron"},{"key":"ref451","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1038\/s41583-018-0055-7","article-title":"Inflammasome signalling in brain function and neurodegenerative disease","volume":"19","author":"Heneka","year":"2018","journal-title":"Nat Rev Neurosci"},{"key":"ref452","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/s41586-019-1769-z","article-title":"NLRP3 inflammasome activation drives tau pathology","volume":"575","author":"Ising","year":"2019","journal-title":"Nature"},{"key":"ref453","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","article-title":"Neuroinflammation in Alzheimer's disease","volume":"14","author":"Heneka","year":"2015","journal-title":"Lancet Neurol"},{"key":"ref454","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1007\/s00281-013-0382-8","article-title":"Microglia and macrophages of the central nervous system: the contribution of microglia priming and systemic inflammation to chronic neurodegeneration","volume":"35","author":"Perry","year":"2013","journal-title":"Semin Immunopathol"},{"key":"ref455","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.pneurobio.2005.06.004","article-title":"Microglia and inflammation-mediated neurodegeneration: multiple triggers with a common mechanism","volume":"76","author":"Block","year":"2005","journal-title":"Prog Neurobiol"},{"key":"ref456","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/610343","article-title":"Surveillance, phagocytosis, and inflammation: how never-resting microglia influence adult hippocampal neurogenesis","volume":"2014","author":"Sierra","year":"2014","journal-title":"Neural Plast"},{"key":"ref457","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1111\/j.1471-4159.2007.04699.x","article-title":"Mechanism of 6-hydroxydopamine neurotoxicity: the role of NADPH oxidase and microglial activation in 6-hydroxydopamine-induced degeneration of dopaminergic neurons","volume":"103","author":"Rodriguez-Pallares","year":"2007","journal-title":"J Neurochem"},{"key":"ref458","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1002\/glia.22765","article-title":"Interaction between NADPH-oxidase and Rho-kinase in angiotensin II-induced microglial activation","volume":"63","author":"Rodriguez-Perez","year":"2015","journal-title":"Glia"},{"key":"ref459","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1016\/j.neurobiolaging.2014.05.021","article-title":"Monoacylglycerol lipase inhibitor JZL184 is neuroprotective and alters glial cell phenotype in the chronic MPTP mouse model","volume":"35","author":"Fern\u00e1ndez-Su\u00e1rez","year":"2014","journal-title":"Neurobiol Aging"},{"key":"ref460","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1038\/npp.2012.255","article-title":"Microglia, amyloid, and glucose metabolism in Parkinson\u2019s disease with and without dementia","volume":"38","author":"Edison","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"ref461","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/7854_2011_165","article-title":"Molecular imaging and the neuropathologies of Parkinson's disease","volume":"11","author":"Cumming","year":"2012","journal-title":"Curr Top Behav Neurosci"},{"key":"ref462","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.parkreldis.2020.11.011","article-title":"Increased microglial activation in patients with Parkinson disease using [","volume":"82","author":"Lavisse","year":"2021","journal-title":"Parkinsonism Relat Disord"},{"key":"ref463","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2012.00096","article-title":"Imaging of microglia in patients with neurodegenerative disorders","volume":"3","author":"Politis","year":"2012","journal-title":"Front Pharmacol"},{"key":"ref464","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/s0896-6273(00)80974-5","article-title":"Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins","volume":"19","author":"Borchelt","year":"1997","journal-title":"Neuron"},{"key":"ref465","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s00429-009-0232-6","article-title":"APP transgenic modeling of Alzheimer\u2019s disease: mechanisms of neurodegeneration and aberrant neurogenesis","volume":"214","author":"Crews","year":"2010","journal-title":"Brain Struct Funct"},{"key":"ref466","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/nm0198-097","article-title":"Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes","volume":"4","author":"Holcomb","year":"1998","journal-title":"Nat Med"},{"key":"ref467","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1002\/jnr.1247","article-title":"Early formation of mature amyloid-beta protein deposits in a mutant APP transgenic model depends on levels of Abeta(1-42)","volume":"66","author":"Rockenstein","year":"2001","journal-title":"J Neurosci Res"},{"key":"ref468","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.bbi.2017.08.015","article-title":"Receptor-heteromer mediated regulation of endocannabinoid signaling in activated microglia. Role of CB1 and CB2 receptors and relevance for Alzheimer\u2019s disease and levodopa-induced dyskinesia","volume":"67","author":"Navarro","year":"2018","journal-title":"Brain Behav Immun"},{"key":"ref469","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1007\/s12035-014-9070-5","article-title":"Differential Roles of M1 and M2 Microglia in Neurodegenerative Diseases","volume":"53","author":"Tang","year":"2016","journal-title":"Mol Neurobiol"},{"key":"ref470","doi-asserted-by":"publisher","DOI":"10.1186\/1742-2094-11-98","article-title":"Neuroinflammation and M2 microglia: the good, the bad, and the inflamed","volume":"11","author":"Cherry","year":"2014","journal-title":"J Neuroinflammation"},{"key":"ref471","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/nn.3599","article-title":"Identification of a unique TGF-\u03b2-dependent molecular and functional signature in microglia","volume":"17","author":"Butovsky","year":"2014","journal-title":"Nat Neurosci"},{"key":"ref472","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1016\/j.ajpath.2011.05.047","article-title":"Reactive glia not only associates with plaques but also parallels tangles in Alzheimer\u2019s disease","volume":"179","author":"Serrano-Pozo","year":"2011","journal-title":"Am J Pathol"},{"key":"ref473","doi-asserted-by":"publisher","first-page":"370","DOI":"10.2174\/1567205013666151116125012","article-title":"Microglia in Alzheimer\u2019s disease: the good, the bad and the ugly","volume":"13","author":"Tejera","year":"2016","journal-title":"Curr Alzheimer Res"},{"key":"ref474","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1002\/glia.23579","article-title":"Blockade of microglial adenosine A","volume":"67","author":"Aires","year":"2019","journal-title":"Glia"},{"key":"ref475","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.trsl.2015.11.005","article-title":"Selective A2A receptor antagonist prevents microglia-mediated neuroinflammation and protects retinal ganglion cells from high intraocular pressure-induced transient ischemic injury","volume":"169","author":"Madeira","year":"2016","journal-title":"Transl Res"},{"key":"ref476","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27092680","article-title":"Pathophysiological Role and Medicinal Chemistry of A","volume":"27","author":"Merighi","year":"2022","journal-title":"Molecules"},{"key":"ref477","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.pharmthera.2011.07.004","article-title":"Past, present and future of A(2A) adenosine receptor antagonists in the therapy of Parkinson\u2019s disease","volume":"132","author":"Armentero","year":"2011","journal-title":"Pharmacol Ther"},{"key":"ref478","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1046\/j.0022-3042.2001.00694.x","article-title":"Neuroprotection by adenosine A2A receptor blockade in experimental models of Parkinson\u2019s disease","volume":"80","author":"Ikeda","year":"2002","journal-title":"J Neurochem"},{"key":"ref479","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-18339-1","article-title":"The effect of istradefylline for Parkinson's disease: A meta-analysis","volume":"7","author":"Sako","year":"2017","journal-title":"Sci Rep"},{"key":"ref480","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/B978-0-12-801022-8.00003-9","article-title":"An overview of adenosine A2A receptor antagonists in Parkinson\u2019s disease","volume":"119","author":"Jenner","year":"2014","journal-title":"Int Rev Neurobiol"},{"key":"ref481","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27072366","article-title":"The Pharmacological Potential of Adenosine A","volume":"27","author":"Mori","year":"2022","journal-title":"Molecules"},{"key":"ref482","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1080\/14737175.2021.1880896","article-title":"Istradefylline - a first generation adenosine A2A antagonist for the treatment of Parkinson\u2019s disease","volume":"21","author":"Jenner","year":"2021","journal-title":"Expert Rev Neurother"},{"key":"ref483","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1111\/j.1750-3639.2003.tb00475.x","article-title":"A1 adenosine receptors accumulate in neurodegenerative structures in Alzheimer disease and mediate both amyloid precursor protein processing and tau phosphorylation and translocation","volume":"13","author":"Angulo","year":"2003","journal-title":"Brain Pathol"},{"key":"ref484","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1111\/j.1471-4159.2005.03395.x","article-title":"Adenosine A2A receptor stimulation potentiates nitric oxide release by activated microglia","volume":"95","author":"Saura","year":"2005","journal-title":"J Neurochem"},{"key":"ref485","doi-asserted-by":"publisher","first-page":"2987","DOI":"10.1021\/acsptsci.4c00457","article-title":"Demystifying the Role of Neuroinflammatory Mediators as Biomarkers for Diagnosis, Prognosis, and Treatment of Alzheimer\u2019s Disease: A Review","volume":"7","author":"Doke","year":"2024","journal-title":"ACS Pharmacol Transl Sci"},{"key":"ref486","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/nrn.2016.7","article-title":"TREM2 variants: new keys to decipher Alzheimer disease pathogenesis","volume":"17","author":"Colonna","year":"2016","journal-title":"Nat Rev Neurosci"},{"key":"ref487","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-015-0366-9","article-title":"Colony-stimulating factor 1 receptor inhibition prevents microglial plaque association and improves cognition in 3xTg-AD mice","volume":"12","author":"Dagher","year":"2015","journal-title":"J Neuroinflammation"},{"key":"ref488","doi-asserted-by":"publisher","DOI":"10.12659\/MSM.925491","article-title":"P2X7 Receptor (P2X7R) of Microglia Mediates Neuroinflammation by Regulating (NOD)-Like Receptor Protein 3 (NLRP3) Inflammasome-Dependent Inflammation After Spinal Cord Injury","volume":"26","author":"Fan","year":"2020","journal-title":"Med Sci Monit"},{"key":"ref489","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1038\/nn1805","article-title":"The P2Y12 receptor regulates microglial activation by extracellular nucleotides","volume":"9","author":"Haynes","year":"2006","journal-title":"Nat Neurosci"},{"key":"ref490","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1126\/science.1202529","article-title":"Synaptic pruning by microglia is necessary for normal brain development","volume":"333","author":"Paolicelli","year":"2011","journal-title":"Science"},{"key":"ref491","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.neuron.2012.03.026","article-title":"Microglia sculpt postnatal neural circuits in an activity and complement-dependent manner","volume":"74","author":"Schafer","year":"2012","journal-title":"Neuron"},{"key":"ref492","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1038\/nn2014","article-title":"Local self-renewal can sustain CNS microglia maintenance and function throughout adult life","volume":"10","author":"Ajami","year":"2007","journal-title":"Nat Neurosci"},{"key":"ref493","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1038\/s41586-019-0924-x","article-title":"Spatial and temporal heterogeneity of mouse and human microglia at single-cell resolution","volume":"566","author":"Masuda","year":"2019","journal-title":"Nature"},{"key":"ref494","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1038\/nm.3407","article-title":"Development, maintenance and disruption of the blood-brain barrier","volume":"19","author":"Obermeier","year":"2013","journal-title":"Nat Med"},{"key":"ref495","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1590\/1980-57642018dn12-020006","article-title":"The association between systemic lupus erythematosus and dementia A meta-analysis","volume":"12","author":"Zhao","year":"2018","journal-title":"Dement Neuropsychol"},{"key":"ref496","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/S0033-3182(85)72860-5","article-title":"Neurosyphilis: a psychiatric perspective","volume":"26","author":"Rundell","year":"1985","journal-title":"Psychosomatics"},{"key":"ref497","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1002\/ana.410260503","article-title":"Neurological and neuropsychological manifestations of HIV-1 infection: association with AIDS-related complex but not asymptomatic HIV-1 infection","volume":"26","author":"Janssen","year":"1989","journal-title":"Ann Neurol"},{"key":"ref498","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-025-01172-3","article-title":"Lower risk of dementia with AS01-adjuvanted vaccination against shingles and respiratory syncytial virus infections","volume":"10","author":"Taquet","year":"2025","journal-title":"NPJ Vaccines"},{"key":"ref499","doi-asserted-by":"publisher","DOI":"10.1126\/science.1255555","article-title":"Alzheimer\u2019s and Parkinson\u2019s diseases: The prion concept in relation to assembled A\u03b2, tau, and \u03b1-synuclein","volume":"349","author":"Goedert","year":"2015","journal-title":"Science"},{"key":"ref500","doi-asserted-by":"publisher","first-page":"3326","DOI":"10.1016\/j.jacc.2019.04.034","article-title":"Vascular Cognitive Impairment and Dementia: JACC Scientific Expert Panel","volume":"73","author":"Iadecola","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"ref501","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1002\/med.21295","article-title":"The challenge of mild traumatic brain injury: role of biochemical markers in diagnosis of brain damage","volume":"34","author":"Mondello","year":"2014","journal-title":"Med Res Rev"},{"key":"ref502","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/bs.acr.2022.04.001","article-title":"Chemobrain: A review on mechanistic insight, targets and treatments","volume":"155","author":"Rao","year":"2022","journal-title":"Adv Cancer Res"},{"key":"ref503","doi-asserted-by":"publisher","first-page":"182","DOI":"10.5694\/mja2.51849","article-title":"Young-onset dementia diagnosis, management and care: a narrative review","volume":"218","author":"Loi","year":"2023","journal-title":"Med J Aust"},{"key":"ref504","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/j.jalz.2016.01.012","article-title":"Molecular genetics of early-onset Alzheimer's disease revisited","volume":"12","author":"Cacace","year":"2016","journal-title":"Alzheimers Dement"},{"key":"ref505","doi-asserted-by":"publisher","first-page":"60S","DOI":"10.2967\/jnumed.121.263201","article-title":"Imaging of Synaptic Density in Neurodegenerative Disorders","volume":"63","author":"Carson","year":"2022","journal-title":"J Nucl Med"},{"key":"ref506","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1517\/17530059.2011.588947","article-title":"Qualifying biomarkers for use in drug development: a US Food and Drug Administration overview","volume":"5","author":"Woodcock","year":"2011","journal-title":"Expert Opin Med Diagn"},{"key":"ref507","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.jalz.2011.05.2351","article-title":"Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: recommendations from the Alzheimer\u2019s Association Research Roundtable Workgroup","volume":"7","author":"Sperling","year":"2011","journal-title":"Alzheimers Dement"},{"key":"ref508","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S1474-4422(12)70015-7","article-title":"Amyloid-related imaging abnormalities in patients with Alzheimer\u2019s disease treated with bapineuzumab: a retrospective analysis","volume":"11","author":"Sperling","year":"2012","journal-title":"Lancet Neurol"},{"key":"ref509","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.862369","article-title":"Amyloid-Related Imaging Abnormalities With Anti-amyloid Antibodies for the Treatment of Dementia Due to Alzheimer\u2019s Disease","volume":"13","author":"Withington","year":"2022","journal-title":"Front Neurol"},{"key":"ref510","doi-asserted-by":"publisher","first-page":"ITC161","DOI":"10.7326\/ANNALS-24-02207","article-title":"Dementia","volume":"177","author":"Oh","year":"2024","journal-title":"Ann Intern Med"},{"key":"ref511","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"\u201cMini-mental state\u201d. A practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J Psychiatr Res"},{"key":"ref512","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.neulet.2007.07.035","article-title":"Grooved pegboard test as a biomarker of nigrostriatal denervation in Parkinson's disease","volume":"424","author":"Bohnen","year":"2007","journal-title":"Neurosci Lett"},{"key":"ref513","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.parkreldis.2005.12.006","article-title":"Wisconsin Card Sorting Test and brain perfusion imaging in Parkinson's disease","volume":"12","author":"Matsui","year":"2006","journal-title":"Parkinsonism Relat Disord"},{"key":"ref514","doi-asserted-by":"publisher","first-page":"410","DOI":"10.5014\/ajot.45.5.410","article-title":"Correlation of perceptual performance and activities of daily living in stroke patients","volume":"45","author":"Titus","year":"1991","journal-title":"Am J Occup Ther"},{"key":"ref515","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1111\/j.2044-8260.1984.tb00634.x","article-title":"Determinants of performance on the Rey-Osterrieth Complex Figure Test: an analysis, and a new technique for single-case assessment","volume":"23","author":"Bennett-Levy","year":"1984","journal-title":"Br J Clin Psychol"},{"key":"ref516","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/BF02214761","article-title":"The California Verbal Learning Test: psychometric characteristics and clinical application","volume":"5","author":"Elwood","year":"1995","journal-title":"Neuropsychol Rev"},{"key":"ref517","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1093\/arclin\/acad036","article-title":"Neuropsychological Performance in Alzheimer\u2019s Disease versus Late-Life Depression: A Systematic Review and Meta-Analysis","volume":"38","author":"Barlet","year":"2023","journal-title":"Arch Clin Neuropsychol"},{"key":"ref518","doi-asserted-by":"publisher","first-page":"460","DOI":"10.2500\/ajr.2007.21.3043","article-title":"Office procedures for quantitative assessment of olfactory function","volume":"21","author":"Doty","year":"2007","journal-title":"Am J Rhinol"},{"key":"ref519","doi-asserted-by":"publisher","first-page":"43","DOI":"10.2174\/1566523220666201123112822","article-title":"Molecular Genetics of Early- and Late-Onset Alzheimer\u2019s Disease","volume":"21","author":"Uddin","year":"2021","journal-title":"Curr Gene Ther"},{"key":"ref520","doi-asserted-by":"publisher","DOI":"10.23937\/IJND-2017\/1710007","article-title":"Identification of PSEN1 and PSEN2 Gene Variants and Clinical Findings with the Literature","volume":"2","author":"Randa","year":"2019","journal-title":"Int J Neurodegener Dis"},{"key":"ref521","doi-asserted-by":"publisher","first-page":"9649","DOI":"10.1073\/pnas.90.20.9649","article-title":"Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease","volume":"90","author":"Schmechel","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref522","doi-asserted-by":"publisher","first-page":"8098","DOI":"10.1073\/pnas.90.17.8098","article-title":"Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease","volume":"90","author":"Strittmatter","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref523","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.biochi.2017.01.009","article-title":"CD36 gene polymorphism is associated with Alzheimer's disease","volume":"135","author":"\u0160er\u00fd","year":"2017","journal-title":"Biochimie"},{"key":"ref524","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.neuroscience.2020.11.003","article-title":"CD36 in Alzheimer\u2019s Disease: An Overview of Molecular Mechanisms and Therapeutic Targeting","volume":"453","author":"Dobri","year":"2021","journal-title":"Neuroscience"},{"key":"ref525","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-15299-z","article-title":"Six genetically linked mutations in the CD36 gene significantly delay the onset of Alzheimer\u2019s disease","volume":"12","author":"\u0160er\u00fd","year":"2022","journal-title":"Sci Rep"},{"key":"ref526","doi-asserted-by":"publisher","DOI":"10.1155\/cdr\/8098173","article-title":"Impacts of","volume":"2025","author":"Luo","year":"2025","journal-title":"Cardiovasc Ther"},{"key":"ref527","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1146\/annurev-anchem-071213-020216","article-title":"High-throughput proteomics","volume":"7","author":"Zhang","year":"2014","journal-title":"Annu Rev Anal Chem (Palo Alto Calif)"},{"key":"ref528","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1038\/s41573-022-00409-3","article-title":"The emerging role of mass spectrometry-based proteomics in drug discovery","volume":"21","author":"Meissner","year":"2022","journal-title":"Nat Rev Drug Discov"},{"key":"ref529","doi-asserted-by":"publisher","first-page":"2415","DOI":"10.1021\/acsptsci.5c00403","article-title":"Use of Proteomics to Explore Biomarkers of Amyotrophic Lateral Sclerosis (ALS): Proof of Principle from Humanized SOD1 Mouse to Human ALS","volume":"8","author":"Sanghai","year":"2025","journal-title":"ACS Pharmacol Transl Sci"},{"key":"ref530","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.71731","article-title":"Alois Alzheimer (1864-1915): The Father of Modern Dementia Research and the Discovery of Alzheimer\u2019s Disease","volume":"16","author":"Thakor","year":"2024","journal-title":"Cureus"},{"key":"ref531","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1177\/1756285612461679","article-title":"Current and future treatments for Alzheimer's disease","volume":"6","author":"Yiannopoulou","year":"2013","journal-title":"Ther Adv Neurol Disord"},{"key":"ref532","doi-asserted-by":"publisher","DOI":"10.37349\/ent.2025.1004118","article-title":"Plasma p-tau217 in Alzheimer\u2019s disease is a dynamic gauge of progression heterogeneity, not a baseline stratifier","volume":"5","author":"Franco","year":"2025","journal-title":"Explor Neuroprot Ther"},{"key":"ref533","doi-asserted-by":"publisher","DOI":"10.1002\/alz.70319","article-title":"Repeated plasma p-tau217 measurements to monitor clinical progression heterogeneity","volume":"21","author":"Kirsebom","year":"2025","journal-title":"Alzheimers Dement"},{"key":"ref534","doi-asserted-by":"publisher","DOI":"10.3390\/metabo14030149","article-title":"Advancing Personalized Medicine by Analytical Means: Selection of Three Metabolites That Allows Discrimination between Glaucoma, Diabetes, and Controls","volume":"14","author":"Bernal-Casas","year":"2024","journal-title":"Metabolites"},{"key":"ref535","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26146991","article-title":"Machine Learning Approach to Select Small Compounds in Plasma as Predictors of Alzheimer\u2019s Disease","volume":"26","author":"Stefanini","year":"2025","journal-title":"Int J Mol Sci"},{"key":"ref536","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.3233\/JAD-200282","article-title":"Heavy Metals Exposure and Alzheimer\u2019s Disease and Related Dementias","volume":"76","author":"Bakulski","year":"2020","journal-title":"J Alzheimers Dis"},{"key":"ref537","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-023-00640-5","article-title":"Pathophysiology and probable etiology of cerebral small vessel disease in vascular dementia and Alzheimer\u2019s disease","volume":"18","author":"Inoue","year":"2023","journal-title":"Mol Neurodegener"},{"key":"ref538","doi-asserted-by":"publisher","first-page":"562","DOI":"10.2214\/AJR.22.28461","article-title":"Amyloid-Related Imaging Abnormalities: An Update","volume":"220","author":"Roytman","year":"2023","journal-title":"AJR Am J Roentgenol"},{"key":"ref539","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000213483","article-title":"Incidence of Amyloid-Related Imaging Abnormalities in Phase III Clinical Trials of Anti-Amyloid-\u03b2 Immunotherapy: An Updated Meta-Analysis","volume":"104","author":"Jeong","year":"2025","journal-title":"Neurology"},{"key":"ref540","doi-asserted-by":"publisher","first-page":"294","DOI":"10.2967\/jnumed.122.264031","article-title":"The RSNA QIBA Profile for Amyloid PET as an Imaging Biomarker for Cerebral Amyloid Quantification","volume":"64","author":"Smith","year":"2023","journal-title":"J Nucl Med"},{"key":"ref541","unstructured":"Biomarkers Inventory - ESR | European Society of Radiology [Internet]. European Society of Radiology; c2025 [cited 2025 Dec 10]. Available from: https:\/\/www.myesr.org\/research\/biomarkers-inventory\/"},{"key":"ref542","doi-asserted-by":"publisher","DOI":"10.1016\/j.pneurobio.2022.102270","article-title":"Amyloid \u03b2, Tau, and \u03b1-Synuclein aggregates in the pathogenesis, prognosis, and therapeutics for neurodegenerative diseases","volume":"214","author":"Sengupta","year":"2022","journal-title":"Prog Neurobiol"},{"key":"ref543","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1055\/a-1839-6237","article-title":"Blood Based Biomarker for Optimization of Early and Differential Diagnosis of Alzheimer\u2019s Dementia","volume":"90","author":"Hansen","year":"2022","journal-title":"Fortschr Neurol Psychiatr"},{"key":"ref544","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1093\/brain\/awad042","article-title":"Predicting amyloid PET and tau PET stages with plasma biomarkers","volume":"146","author":"Jack","year":"2023","journal-title":"Brain"},{"key":"ref545","doi-asserted-by":"publisher","first-page":"355","DOI":"10.3233\/ADR-230029","article-title":"Plasma Biomarkers of Alzheimer\u2019s Disease: A Review of Available Assays, Recent Developments, and Implications for Clinical Practice","volume":"7","author":"Pais","year":"2023","journal-title":"J Alzheimers Dis Rep"},{"key":"ref546","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1111\/joim.12816","article-title":"Biomarkers for Alzheimer\u2019s disease: current status and prospects for the future","volume":"284","author":"Blennow","year":"2018","journal-title":"J Intern Med"},{"key":"ref547","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1001\/archneur.64.3.noc60123","article-title":"Cerebrospinal fluid tau\/beta-amyloid(42) ratio as a prediction of cognitive decline in nondemented older adults","volume":"64","author":"Fagan","year":"2007","journal-title":"Arch Neurol"},{"key":"ref548","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA Research Framework: Toward a biological definition of Alzheimer\u2019s disease","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimers Dement"},{"key":"ref549","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1212\/WNL.0000000000200878","article-title":"\u03b1-Synuclein Seed Amplification Assays for Diagnosing Synucleinopathies: The Way Forward","volume":"99","author":"Bellomo","year":"2022","journal-title":"Neurology"},{"key":"ref550","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1097\/WCO.0000000000001285","article-title":"An update on multiple system atrophy","volume":"37","author":"Stankovic","year":"2024","journal-title":"Curr Opin Neurol"},{"key":"ref551","doi-asserted-by":"publisher","first-page":"499","DOI":"10.2217\/bmm-2021-0646","article-title":"Synuclein-One study: skin biopsy detection of phosphorylated \u03b1-synuclein for diagnosis of synucleinopathies","volume":"16","author":"Gibbons","year":"2022","journal-title":"Biomark Med"},{"key":"ref552","doi-asserted-by":"publisher","first-page":"2755","DOI":"10.1093\/brain\/awac161","article-title":"Tau protein quantification in skin biopsies differentiates tauopathies from alpha-synucleinopathies","volume":"145","author":"Vacchi","year":"2022","journal-title":"Brain"},{"key":"ref553","doi-asserted-by":"publisher","first-page":"e2513","DOI":"10.1212\/WNL.0000000000011935","article-title":"In Vivo Diagnosis of Synucleinopathies: A Comparative Study of Skin Biopsy and RT-QuIC","volume":"96","author":"Donadio","year":"2021","journal-title":"Neurology"},{"key":"ref554","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-024-00728-9","article-title":"Tau seeding activity in skin biopsy differentiates tauopathies from synucleinopathies","volume":"10","author":"Dellarole","year":"2024","journal-title":"NPJ Parkinsons Dis"},{"key":"ref555","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/j.neurobiolaging.2004.07.007","article-title":"Fibroblast glutamate transport in aging and in AD: correlations with disease severity","volume":"26","author":"Zoia","year":"2005","journal-title":"Neurobiol Aging"},{"key":"ref556","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1517\/13543784.8.10.1599","article-title":"Neuroprotection by caspase inhibitors","volume":"8","author":"Braun","year":"1999","journal-title":"Expert Opin Investig Drugs"},{"key":"ref557","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1517\/14728214.6.1.81","article-title":"Caspase inhibitors as neuroprotective agents","volume":"6","author":"Legos","year":"2001","journal-title":"Expert Opin Emerg Drugs"},{"key":"ref558","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1093\/eurjpc\/zwab208","article-title":"Statin use and risk of dementia or Alzheimer\u2019s disease: a systematic review and meta-analysis of observational studies","volume":"29","author":"Olmastroni","year":"2022","journal-title":"Eur J Prev Cardiol"},{"key":"ref559","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/8961493","article-title":"Exercise-Induced Neuroplasticity in Parkinson\u2019s Disease: A Metasynthesis of the Literature","volume":"2020","author":"Johansson","year":"2020","journal-title":"Neural Plast"},{"key":"ref560","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2024.102231","article-title":"Lithium and disease modification: A systematic review and meta-analysis in Alzheimer\u2019s and Parkinson\u2019s disease","volume":"95","author":"Singulani","year":"2024","journal-title":"Ageing Res Rev"},{"key":"ref561","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001447.pub3","article-title":"Riluzole for amyotrophic lateral sclerosis (ALS)\/motor neuron disease (MND)","volume":"2012","author":"Miller","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"ref562","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1093\/brain\/awz030","article-title":"Risk and predictors of dementia and parkinsonism in idiopathic REM sleep behaviour disorder: a multicentre study","volume":"142","author":"Postuma","year":"2019","journal-title":"Brain"},{"key":"ref563","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1002\/ana.20741","article-title":"1,026 experimental treatments in acute stroke","volume":"59","author":"O\u2019Collins","year":"2006","journal-title":"Ann Neurol"},{"key":"ref564","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1176\/appi.ajp.2015.14121582","article-title":"Pharmacological Management of Lewy Body Dementia: A Systematic Review and Meta-Analysis","volume":"172","author":"Stinton","year":"2015","journal-title":"Am J Psychiatry"},{"key":"ref565","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1161\/STROKEAHA.110.596718","article-title":"Molecular pathophysiology of cerebral hemorrhage: secondary brain injury","volume":"42","author":"Aronowski","year":"2011","journal-title":"Stroke"},{"key":"ref566","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1111\/j.1442-9071.2011.02563.x","article-title":"Translational neuroprotection research in glaucoma: a review of definitions and principles","volume":"40","author":"Casson","year":"2012","journal-title":"Clin Exp Ophthalmol"},{"key":"ref567","doi-asserted-by":"publisher","DOI":"10.3390\/cells13151288","article-title":"The Potential of Metabolomics to Find Proper Biomarkers for Addressing the Neuroprotective Efficacy of Drugs Aimed at Delaying Parkinson\u2019s and Alzheimer\u2019s Disease Progression","volume":"13","author":"Franco","year":"2024","journal-title":"Cells"},{"key":"ref568","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.39048.407928.BE","article-title":"Comparison of treatment effects between animal experiments and clinical trials: systematic review","volume":"334","author":"Perel","year":"2007","journal-title":"BMJ"},{"key":"ref569","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-018-1678-1","article-title":"Is it possible to overcome issues of external validity in preclinical animal research? Why most animal models are bound to fail","volume":"16","author":"Pound","year":"2018","journal-title":"J Transl Med"},{"key":"ref570","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.1002273","article-title":"Risk of Bias in Reports of In Vivo Research: A Focus for Improvement","volume":"13","author":"Macleod","year":"2015","journal-title":"PLoS Biol"},{"key":"ref571","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2014.00146","article-title":"Successful therapies for Alzheimer\u2019s disease: why so many in animal models and none in humans?","volume":"5","author":"Franco","year":"2014","journal-title":"Front Pharmacol"},{"key":"ref572","doi-asserted-by":"publisher","DOI":"10.3389\/fragi.2021.727604","article-title":"Vascular Aging in Rodent Models: Contrasting Mechanisms Driving the Female and Male Vascular Senescence","volume":"2","author":"Barros","year":"2021","journal-title":"Front Aging"},{"key":"ref573","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1210\/en.2004-1142","article-title":"Strategies and methods for research on sex differences in brain and behavior","volume":"146","author":"Becker","year":"2005","journal-title":"Endocrinology"},{"key":"ref574","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1177\/0023677216653984","article-title":"Does age matter? The impact of rodent age on study outcomes","volume":"51","author":"Jackson","year":"2017","journal-title":"Lab Anim"},{"key":"ref575","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23042397","article-title":"Diabetes and Ischemic Stroke: An Old and New Relationship an Overview of the Close Interaction between These Diseases","volume":"23","author":"Maida","year":"2022","journal-title":"Int J Mol Sci"},{"key":"ref576","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.cobeha.2018.05.007","article-title":"Sex Differences in the Neuroimmune System","volume":"23","author":"Osborne","year":"2018","journal-title":"Curr Opin Behav Sci"},{"key":"ref577","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2018.00071","article-title":"A Comparison of Pathophysiology in Humans and Rodent Models of Subarachnoid Hemorrhage","volume":"11","author":"Leclerc","year":"2018","journal-title":"Front Mol Neurosci"},{"key":"ref578","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1161\/STROKEAHA.122.040638","article-title":"Embracing Heterogeneity in The Multicenter Stroke Preclinical Assessment Network (SPAN) Trial","volume":"54","author":"Morais","year":"2023","journal-title":"Stroke"},{"key":"ref579","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2018.00984","article-title":"Neurofilament Light Chain: Blood Biomarker of Neonatal Neuronal Injury","volume":"9","author":"Depoorter","year":"2018","journal-title":"Front Neurol"},{"key":"ref580","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1136\/jnnp-2018-320106","article-title":"Neurofilament light chain as a biomarker in neurological disorders","volume":"90","author":"Gaetani","year":"2019","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref581","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2020.00579","article-title":"Neurofilament-Light Chain as Biomarker of Neurodegenerative and Rare Diseases With High Translational Value","volume":"14","author":"Loeffler","year":"2020","journal-title":"Front Neurosci"},{"key":"ref582","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1002\/cpt.3661","article-title":"Participants in the FDA's Biomarker Qualification Program","volume":"118","author":"Shahzad","year":"2025","journal-title":"Clin Pharmacol Ther"},{"key":"ref583","doi-asserted-by":"publisher","DOI":"10.1155\/2024\/6668159","article-title":"Novel Biomarkers for Alzheimer's Disease: Plasma Neurofilament Light and Cerebrospinal Fluid","volume":"2024","author":"Abukuri","year":"2024","journal-title":"Int J Alzheimers Dis"},{"key":"ref584","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.78900","article-title":"Limitations of the Glasgow Coma Scale: Challenges and Considerations","volume":"17","author":"Andraos","year":"2025","journal-title":"Cureus"},{"key":"ref585","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/s41582-018-0058-z","article-title":"Neurofilaments as biomarkers in neurological disorders","volume":"14","author":"Khalil","year":"2018","journal-title":"Nat Rev Neurol"},{"key":"ref586","doi-asserted-by":"publisher","DOI":"10.3390\/life15060883","article-title":"How to Pick a Neuroprotective Drug in Stroke Without Losing Your Mind?","volume":"15","author":"Tauskela","year":"2025","journal-title":"Life (Basel)"},{"key":"ref587","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2025.102775","article-title":"Advances in Alzheimer\u2019s therapy: Exploring neuropathological mechanisms to revolutionize the future therapeutic landscape","volume":"109","author":"Sugandhi","year":"2025","journal-title":"Ageing Res Rev"},{"key":"ref588","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-023-00535-8","article-title":"Different pieces of the same puzzle: a multifaceted perspective on the complex biological basis of Parkinson\u2019s disease","volume":"9","author":"M\u00fcller-Nedebock","year":"2023","journal-title":"NPJ Parkinsons Dis"},{"key":"ref589","doi-asserted-by":"publisher","first-page":"2868","DOI":"10.1021\/acsptsci.5c00077","article-title":"Harnessing Metabolism to Combat Neurodegeneration: Strategies for Reversing Age-Related Cognitive Decline","volume":"8","author":"Jain","year":"2025","journal-title":"ACS Pharmacol Transl Sci"},{"key":"ref590","doi-asserted-by":"publisher","first-page":"5860","DOI":"10.1002\/alz.13390","article-title":"Artificial intelligence for biomarker discovery in Alzheimer\u2019s disease and dementia","volume":"19","author":"Winchester","year":"2023","journal-title":"Alzheimers Dement"},{"key":"ref591","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci15040351","article-title":"Advances of Artificial Intelligence in Neuroimaging","volume":"15","author":"Beheshti","year":"2025","journal-title":"Brain Sci"},{"key":"ref592","doi-asserted-by":"publisher","DOI":"10.3389\/fnhum.2025.1552178","article-title":"Integration of multimodal imaging data with machine learning for improved diagnosis and prognosis in neuroimaging","volume":"19","author":"Bhattacharya","year":"2025","journal-title":"Front Hum Neurosci"},{"key":"ref593","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2025.102739","article-title":"Fluid-based biomarkers for neurodegenerative diseases","volume":"108","author":"Cao","year":"2025","journal-title":"Ageing Res Rev"},{"key":"ref594","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1002\/alz.12131","article-title":"Amyloid beta, tau, synaptic, neurodegeneration, and glial biomarkers in the preclinical stage of the Alzheimer\u2019s continuum","volume":"16","author":"Mil\u00e0-Alom\u00e0","year":"2020","journal-title":"Alzheimers Dement"},{"key":"ref595","doi-asserted-by":"publisher","DOI":"10.25259\/SNI_773_2023","article-title":"Neuroprotection strategies in traumatic brain injury: Studying the effectiveness of different clinical approaches","volume":"15","author":"Buccilli","year":"2024","journal-title":"Surg Neurol Int"},{"key":"ref596","doi-asserted-by":"publisher","DOI":"10.3389\/fnimg.2023.1147508","article-title":"Development of a Bayesian multimodal model to detect biomarkers in neuroimaging studies","volume":"2","author":"Bhaumik","year":"2023","journal-title":"Front Neuroimaging"},{"key":"ref597","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1016\/S0140-6736(15)60461-5","article-title":"A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial","volume":"385","author":"Ngandu","year":"2015","journal-title":"Lancet"},{"key":"ref598","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1002\/alz.12123","article-title":"World-Wide FINGERS Network: A global approach to risk reduction and prevention of dementia","volume":"16","author":"Kivipelto","year":"2020","journal-title":"Alzheimers Dement"},{"key":"ref599","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232213775","article-title":"Neuroprotection and Non-Invasive Brain Stimulation: Facts or Fiction?","volume":"23","author":"Guidetti","year":"2022","journal-title":"Int J Mol Sci"},{"key":"ref600","doi-asserted-by":"publisher","DOI":"10.1186\/s40001-024-02172-0","article-title":"Research on magnetic resonance imaging in diagnosis of Alzheimer\u2019s disease","volume":"29","author":"Zhao","year":"2024","journal-title":"Eur J Med Res"},{"key":"ref601","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1136\/jnnp-2021-328623","article-title":"Tau-PET imaging predicts cognitive decline and brain atrophy progression in early Alzheimer\u2019s disease","volume":"93","author":"Lagarde","year":"2022","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref602","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.neurobiolaging.2025.07.007","article-title":"White matter hyperintensities contribute to early cortical thinning in addition to tau in aging","volume":"155","author":"Leone","year":"2025","journal-title":"Neurobiol Aging"},{"key":"ref603","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-49949-9","article-title":"Neuroimaging and fluid biomarkers in Parkinson\u2019s disease in an era of targeted interventions","volume":"15","author":"Zarkali","year":"2024","journal-title":"Nat Commun"},{"key":"ref604","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-024-01495-8","article-title":"A multidomain lifestyle intervention to maintain optimal cognitive functioning in Dutch older adults-study design and baseline characteristics of the FINGER-NL randomized controlled trial","volume":"16","author":"Deckers","year":"2024","journal-title":"Alzheimers Res Ther"},{"key":"ref605","doi-asserted-by":"publisher","DOI":"10.3390\/bios15070410","article-title":"AI-Driven Wearable Bioelectronics in Digital Healthcare","volume":"15","author":"Huang","year":"2025","journal-title":"Biosensors (Basel)"},{"key":"ref606","doi-asserted-by":"publisher","first-page":"38","DOI":"10.4103\/picr.picr_219_22","article-title":"The role of remote data capture, wearables, and digital biomarkers in decentralized clinical trials","volume":"15","author":"Chodankar","year":"2024","journal-title":"Perspect Clin Res"},{"key":"ref607","doi-asserted-by":"publisher","DOI":"10.1016\/j.bios.2023.115387","article-title":"The convergence of traditional and digital biomarkers through AI-assisted biosensing: A new era in translational diagnostics?","volume":"235","author":"Arya","year":"2023","journal-title":"Biosens Bioelectron"},{"key":"ref608","doi-asserted-by":"publisher","first-page":"e111","DOI":"10.1016\/j.jalz.2013.05.1769","article-title":"The Alzheimer\u2019s Disease Neuroimaging Initiative: a review of papers published since its inception","volume":"9","author":"Weiner","year":"2013","journal-title":"Alzheimers Dement"},{"key":"ref609","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-01845-y","article-title":"An integrated deep learning model for early and multi-class diagnosis of Alzheimer\u2019s disease from MRI scans","volume":"15","author":"Vinukonda","year":"2025","journal-title":"Sci Rep"},{"key":"ref610","doi-asserted-by":"publisher","DOI":"10.1002\/trc2.70114","article-title":"Digital biomarkers: Redefining clinical outcomes and the concept of meaningful change","volume":"11","author":"Iulita","year":"2025","journal-title":"Alzheimers Dement (N Y)"},{"key":"ref611","doi-asserted-by":"publisher","DOI":"10.1186\/s43055-024-01356-2","article-title":"Explainability, transparency and black box challenges of AI in radiology: impact on patient care in cardiovascular radiology","volume":"55","author":"Marey","year":"2024","journal-title":"Egypt J Radiol Nucl Med"},{"key":"ref612","unstructured":"Neurotechnology and neurorights \u2013 Privacy\u2019s last frontier [Internet]. European Parliament; [cited 2025 Jul 17]. Available from: https:\/\/www.europarl.europa.eu\/thinktank\/de\/events\/details\/neurotechnology-and-neurorights-privacy-\/20231019WKS05721"},{"key":"ref613","doi-asserted-by":"publisher","DOI":"10.1186\/s40504-017-0050-1","article-title":"Towards new human rights in the age of neuroscience and neurotechnology","volume":"13","author":"Ienca","year":"2017","journal-title":"Life Sci Soc Policy"},{"key":"ref614","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.3002903","article-title":"The promises and challenges of neurotechnology to improve human health and cognition","volume":"22","author":"Hanslmayr","year":"2024","journal-title":"PLoS Biol"},{"key":"ref615","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2025.101982","article-title":"The gut microbiota-immune-brain axis: Therapeutic implications","volume":"6","author":"O\u2019Riordan","year":"2025","journal-title":"Cell Rep Med"},{"key":"ref616","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.neuron.2019.01.021","article-title":"Effects of Species-Specific Genetics on Alzheimer\u2019s Mouse Models","volume":"101","author":"Hyman","year":"2019","journal-title":"Neuron"},{"key":"ref617","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neuroscience.2025.07.003","article-title":"Parkinson\u2019s disease and the gut microbiota connection: unveiling dysbiosis and exploring therapeutic horizons","volume":"581","author":"Yadav","year":"2025","journal-title":"Neuroscience"},{"key":"ref618","doi-asserted-by":"publisher","DOI":"10.1128\/msystems.00295-24","article-title":"Meta-analysis of the human gut microbiome uncovers shared and distinct microbial signatures between diseases","volume":"9","author":"Jin","year":"2024","journal-title":"mSystems"},{"key":"ref619","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2025.117905","article-title":"Microbial signatures and therapeutic strategies in neurodegenerative diseases","volume":"184","author":"Rob","year":"2025","journal-title":"Biomed Pharmacother"},{"key":"ref620","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurot.2024.e00441","article-title":"Microbiome and micronutrient in ALS: From novel mechanisms to new treatments","volume":"21","author":"Sun","year":"2024","journal-title":"Neurotherapeutics"},{"key":"ref621","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26178419","article-title":"The Emerging Role of the Brain-Gut Axis in Amyotrophic Lateral Sclerosis: Pathogenesis, Mechanisms, and Therapeutic Perspectives","volume":"26","author":"Yang","year":"2025","journal-title":"Int J Mol Sci"},{"key":"ref622","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202413197","article-title":"Advances in Fecal Microbiota Transplantation for Gut Dysbiosis-Related Diseases","volume":"12","author":"Hou","year":"2025","journal-title":"Adv Sci (Weinh)"},{"key":"ref623","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1002\/nep3.70000","article-title":"Targeting gut microbiota as a therapeutic approach for neurodegenerative diseases","volume":"3","author":"Olajide","year":"2025","journal-title":"Neuroprotection"},{"key":"ref624","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1582119","article-title":"Gut microbiota-driven neuroinflammation in Alzheimer\u2019s disease: from mechanisms to therapeutic opportunities","volume":"16","author":"Lei","year":"2025","journal-title":"Front Immunol"},{"key":"ref625","doi-asserted-by":"publisher","DOI":"10.3390\/nu17030558","article-title":"Protective Effects of Bifidobacterium Breve MCC1274 as a Novel Therapy for Alzheimer's Disease","volume":"17","author":"Abdelhamid","year":"2025","journal-title":"Nutrients"},{"key":"ref626","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26115351","article-title":"Microbiome Engineering for Biotherapeutic in Alzheimer's Disease Through the Gut-Brain Axis: Potentials and Limitations","volume":"26","author":"Renesteen","year":"2025","journal-title":"Int J Mol Sci"},{"key":"ref627","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2022.111572","article-title":"Short chain fatty acids: Microbial metabolites for gut-brain axis signalling","volume":"546","author":"O\u2019Riordan","year":"2022","journal-title":"Mol Cell Endocrinol"},{"key":"ref628","doi-asserted-by":"publisher","DOI":"10.1136\/gpsych-2023-101374","article-title":"Gut microbiota-derived short-chain fatty acids and depression: deep insight into biological mechanisms and potential applications","volume":"37","author":"Cheng","year":"2024","journal-title":"Gen Psychiatr"},{"key":"ref629","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1001\/jamaneurol.2018.3444","article-title":"Biomarkers for Alzheimer Dementia in Diverse Racial and Ethnic Minorities-A Public Health Priority","volume":"76","author":"Barnes","year":"2019","journal-title":"JAMA Neurol"},{"key":"ref630","doi-asserted-by":"publisher","article-title":"Baseline levels and longitudinal rates of change in plasma A\u03b242\/40 among self-identified Black\/African American and White individuals","author":"Xiong","DOI":"10.21203\/rs.3.rs-3783571\/v1"},{"key":"ref631","unstructured":"Kolbe A. HHS Actions to Enhance Diversity in Clinical Research: Issue Brief"},{"key":"ref632","doi-asserted-by":"publisher","unstructured":"Improving Representation in Clinical Trials and Research: Building Research Equity for Women and Underrepresented Groups. Bibbins-Domingo K, Helman A, editor. National Academies of Sciences, Engineering, and Medicine; Policy and Global Affairs; Committee on Women in Science, Engineering, and Medicine; Committee on Improving the Representation of Women and Underrepresented Minorities in Clinical Trials and Research","DOI":"10.17226\/26479"},{"key":"ref633","doi-asserted-by":"publisher","DOI":"10.1080\/16549716.2020.1846904","article-title":"Strengthening research capacity in LMICs to address the global NCD burden","volume":"13","author":"Malekzadeh","year":"2020","journal-title":"Glob Health Action"},{"key":"ref634","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2023.1128619","article-title":"The future is precision medicine-guided diagnoses, preventions and treatments for neurodegenerative diseases","volume":"15","author":"Rossi","year":"2023","journal-title":"Front Aging Neurosci"},{"key":"ref635","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-018-1017-7","article-title":"Adaptive designs in clinical trials: why use them, and how to run and report them","volume":"16","author":"Pallmann","year":"2018","journal-title":"BMC Med"},{"key":"ref636","doi-asserted-by":"publisher","DOI":"10.3390\/math13081273","article-title":"Advances in Clinical Trial Design: Employing Adaptive Multiple Testing and Neyman Allocation for Unequal Samples","volume":"13","author":"Hammouri","year":"2025","journal-title":"Mathematics"},{"key":"ref637","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines12122750","article-title":"Revolutionizing Personalized Medicine: Synergy with Multi-Omics Data Generation, Main Hurdles, and Future Perspectives","volume":"12","author":"Molla","year":"2024","journal-title":"Biomedicines"},{"key":"ref638","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.lungcan.2016.06.003","article-title":"Integration of multiple \u201cOMIC\u201d biomarkers: A precision medicine strategy for lung cancer","volume":"107","author":"Robles","year":"2017","journal-title":"Lung Cancer"},{"key":"ref639","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.brainres.2015.10.047","article-title":"Neuroprotection: Basic mechanisms and translational potential","volume":"1628","author":"Iacovitti","year":"2015","journal-title":"Brain Res"}],"container-title":["Exploration of Neuroprotective Therapy"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,1,4]],"date-time":"2026-01-04T04:53:13Z","timestamp":1767502393000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.explorationpub.com\/Journals\/ent\/Article\/1004136"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,4]]},"references-count":639,"URL":"https:\/\/doi.org\/10.37349\/ent.2026.1004136","archive":["Portico","Portico"],"relation":{},"ISSN":["2769-6510"],"issn-type":[{"value":"2769-6510","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,4]]},"assertion":[{"value":"2025-08-17","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-11-24","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-01-04","order":2,"name":"published","label":"Published Online","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"1004136"}}